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1. Introduction 
 
“THE LORD HAS CREATED MEDICINES OUT OF THE EARTH AND HE WHO 
IS WISE WILL NOT ABHOR THEM” 
-ECCLESIATES, CHAPTER-38, VERSE-4. 
Over 120 medicinal plants are found in the bible including aloe, rue, madder, frankincense, myrrh 
and marigold. This shows the belief people had in herbs.
1 
 
“NOWHERE ON EARTH IS THERE ANY CREATURE WHICH IS IMMORTAL. YET 
ALTHOUGH DEATH IS UNAVOIDABLE A MAN MAY AVOID MANY DISEASES. 
HEALTH BRINGS HAPPINESS.” 
   -SARNGADHARA SAMHITA, SECTION-1.5. 
One can avoid disease, when the food what he consumes is itself exhibits rich medicinal value. 
This is possible when he/she includes our traditional herbs in their diet.
2
 
 
World population is becoming 5 billion and with this rate of growth it is likely to 
touch 7 billion by 2020. Global estimates indicate that over three forth of the population 
cannot afford the products of the western pharmaceuticxal industry and have to rely upon the 
use f traditional medicines, which are mainly derived from plants. As a part f strategy to 
reduce financial burden on the developing countries  which spend 40-50 of their total health 
budget on drugs , WHO currently encourages recommends and promotes the inclusion of 
herbal drug in National health care programmes as such drugs are easily available at aprice 
within the reach of a commaon man and as such are time tested and thus considered to be 
much safer than modern synthetic drugs. 
  Plants have curative measure for all ailments but man has to discover it out. Herbs act 
in almost magical and astonishing ways. However , the ultimate objective of their use is that 
they should interact directly with our body chemistry. Their active constituents must be 
absorbed in the blood stream, they circulate, to influence our whole system.
3
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The following statistics gives an alarming picture about anaemia: 
o 56% of Indian women suffer fromanaemia4 
o 4 out of 5 children in the age of 6-35 months suffer fromanaemia5 
o 20% of maternal deaths are due to anaemia and anaemia indirectly 
contributes to another 40% of maternal deaths and maternal mortality is 
staggeringly high at 454 per every 100000 livebirths.
6
 
o Anaemia spares none; it affects both adults and children of bothsex. 
 
    ANAEMIA
7 
 
Decrease below normal of haemoglobin  concentration or RBC count or hematocrit  (PCV). 
Reduction of total circulating red cell mass below normal limits. 
Decrease in oxygen carrying which leads to hypoxia . 
Anemia is characterized by decreased oxygen carrying capacity of blood 
WHO criteria for anemia 
Adult males: Haemoglobin less than 13g /dl 
Adult female: Haemoglobin less than 12g/dl 
Grading of anemia 
Mild: Haemoglobin 9.1 -10.5g/dl 
Moderate: Haemoglobin 6.0-9.0g/dl 
Severe: Haemoglobin<6.0g/dl 
 
CLASSIFICATION 
I.MORPHOLOGICAL CLASSIFICATION: 
It is based on  
a) Red cell size(Normocytic,microcytic,macrocytic) 
b) Degree of haemoglobinization:(normochromic,hypocromic) 
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Table 1.1 Types of anemia 
 
Type of anemia Microcytic,hypochromic Normocytic, 
normochromic 
Macrocytic 
Size of RBC Smaller than normal Normal Larger than 
normal 
Central pallor in 
RBC 
More than 1/3 Normal Normal 
Mean corpuscular 
volume(MCV) 
Reduced(<80fL) Normal(82-98fL) Increased(>100fL) 
MCHC Reduced(<30g/dl) Normal(31-36g/dl) Normal(31-
36g/dl) 
Examples Iron deficiency anemia, 
Thalassemia 
During blood loss, anemia 
of chronic disease 
Deficiency of 
vitamin B12 and 
folic acid 
Morphology of 
RBC 
 
 
 
 
 
 
  
 
II.ETIOLOGICAL CLASSIFICATION 
i) Decrease in RBC production. 
ii) Increase in RBC destruction. 
iii) Blood loss. 
1.IMPAIRED RED CELL PRODUCTION 
                 1.1.a)Disturbed Proliferation and Maturation of Erythroblasts 
  ►Defective DNA synthesis 
 Megaloblastic Anemia due to deficiency or impaired utilization of 
vitamin B12 or Folic acid. 
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 Anemia of renal failure due to deficiency of erythropoietin 
 Anemia of chronic disease due to iron sequestration and relative 
erythropoietin deficiency 
 Anemia of endocrine disorders 
   b) Defective Haemoglobin Synthesis 
                      ►Defective heme synthesis 
 Iron deficiency , Sideroblastic anemia 
         ►Defective Globin Synthesis 
 Thalassemias 
 
               1.2) Marrow replacement  
                   a) Primary hepmatopoietic neoplasm 
 Acute Leukemia 
 Mylelodysplastic Syndrome 
              1.3)Marrow  Infiltraton  
    a) Metastatic Neoplasm 
 1.4) Disturbed  proliferation and differentiation of stem cells. 
    a) .Aplastic anemia, pure red cell aplasia. 
 2.INCREASED RED CELL DESTRUCTION(Hemolytic anemias) 
    2.1) Intrinsic (Intra corpuscular) Abnormalities 
      a) Hereditary 
         ►membrane abnormalities  
 Spherocytosis 
 Elliptocytosis 
►Enzyme deficiencies 
 Glucose-6-Phosphate dehydrogenase  
 Pyruvate Kinase 
 ► Disorders of hemoglobin Synthesis 
    ►Defective Globin Synthesis 
 Thalassemias 
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                   ►Structurally abnormal globin Synthesis 
 Sickle Cell Anemia 
b)Acquired 
         ►Membrane defects 
 Paroxysmal Noutunal hemoglobinuria 
2.2)Extrinsic(Extra corpuscular Abnormalities) 
a)Antibody – Mediated  
   ► Isohemagglutinins- transfusion reaction  
 Rh disease of New born 
 
  ► Auto antibodies  
 Idiopathic 
 Drug associated 
 Systemic Lupus erythematous 
b)Mechanical trauma to RBCs 
► micro angiopathic hemolytic anemia 
 Disseminated intra vascular  coagulation. 
 c)Infections  
 Malaria. 
3)BLOOD LOSS 
        ►Acute: Trauma 
        ► Chronic: Leisons of GIT, Gynecological disturbances. 
RED CELL INDICES 
 Red cell indices are useful in Morphological characterization and diagnosis of 
anemias. 
 They can be calculated automatically  or using specialized instruments. 
 The  four significant  Red Cell Indices are: 
 MCV-Mean Corpuscular Volume. 
 MCH- Mean Corpuscular Haemoglobin. 
 MCHC- Mean Corpuscular  Haemoglobin Concentration. 
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 RDW- Red Cell Distribution width. 
 
I. MCV-Mean Corpuscular Volume 
It is defined as the average number of  Red Blood Cells. 
It is expressed in femolitres(fL) 
This proves very useful in diagnosis 
Normal range: 82-98 fL 
MCV=  PCVx1000                    = 0.45X1000/ 5 = 90fL. 
RBC Count (millions)  
 
II. MCH- Mean Corpuscular Haemoglobin 
It is defined as the amount of Haemoglobin per Red Blood Cell 
It is expressed in Picograms 
It has limited value in diagnosis 
Normal range: 27-32pg 
 
MCH= Haemoglobin (in g/L)    =15X10  = 30pg 
             RBC (in millions/μL)          5 
 
 
III. MCHC- Mean Corpuscular  Haemoglobin Concentration 
It is defined as the average number of  Haemoglobin in RBC taking volume into 
consideration. 
It si expressed in g/dL. 
Normal range: 31-35g/dL. 
MCHC= Haemoglobin(in g/dL)   = 15    = 33g/dL 
                Packed Cell Volume       0.45 
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IV. RDW- Red Cell Distribution width. 
It is a quantitative measure of anisocytosis. 
Normal range = 11.5% - 14.5% 
Normal RDW indicates RBC uniform in size . 
Increased RDW tells that RBC are heterogenous in size and shape 
Early Iron deficiency Anemia: RDW increased with low MCV 
Thalassemia : RDW normal with low MCV 
RDW = Standard deviation   X  100 
                       MCV 
Increased RDW  >15% is the early sign of Iron deficiency  anemia. 
 
 
SIGNS AND SYMPTOMS OF ANAEMIA
8
 
Skin 
Skin becomes pale, buccal and pharyngeal mucous membrane shows 
prominent paleness in conjunctivae, lips, ear lobes, palm and nail bed. Skin becomes 
thin and dry losing its elasticity, early greyness, thinning and loss of hair can occur. 
Nails become brittle and easily breakable. 
 
Cardiovascular system 
Anaemia can cause tachycardia and increased velocity of blood flow and 
cardiac murmurs are observed. 
 
RESPIRATION 
Force and rate of respiration is increased sometimes it may lead to 
breathlessness and dyspnoea. Oxygen haemoglobin dissociation curve is shifted to 
right. 
                                                                               Introduction 
 
Department of Pharmacognosy, MMC, Chennai-3.  Page 8 
 
 
DIGESTION 
The common symptoms of anaemia are anorexia, nausea, vomiting, abdominal 
discomfort and constipation. 
 
METABOLISM 
Basal metabolic rate is increased in severe anaemia. 
 
KIDNEY 
Albuminuria is common and renal function is disturbed. 
 
REPRODUCTIVE SYSTEM 
In females, the menstrual cycle is disturbed. Menorrhagia, oligomenorrhagia  
or amenorrhea is accompanied withanaemia. 
 
NEUROMUSCULAR SYSTEM 
Headache, lack of concentration, restlessness, irritability, drowsiness, 
dizziness or vertigo especially when standing, increased sensitivity to cold and  
fainting sensation are common symptoms. Muscles become weak and there is lack of 
energy andfatigue. 
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Agents used to treat anaemia
9
 
 
Iron 
Iron is stored in intestinal mucosal cells as ferritin. Iron deficiency resultsfrom a negative 
iron balance due to depletion of iron stores, acute chronic blood loss and insufficient 
intake during periods of accelerated growth in children, heavy menstruation and/or 
inadequate intake of iron in diet. Supplementation with ferrous sulphate is required to 
correct the deficiency. 
 
Adverse effect 
GI disturbance caused by local irritation are the most common adverse effects. 
 
 
Folic acid 
Folic acid is used in treating deficiency states that arise from inadequate levels 
of vitamin. Folate deficiency may be caused by increased demand (during pregnancy 
and lactation), poor absorption caused by pathology of small intestine, alcoholism or 
treatment with drugs that are dihydro folate reductase inhibitors. Folic acid is  
normally well absorbed in jejunum. Oral folic acid administration isnontoxic. 
Adverse effects 
Rare hypersensitivity reactions to parenteral injections have been reported. 
 
Cyanocobalamine 
Vitamin B12 deficiency results from low dietary levels, poor absorption of the 
vitamin due to failure of gastric parietal cells to produce intrinsic factor or loss of 
receptor activity for the intestinal uptake of the vitamin. Vit.B12 supplementation is 
required in the large oral doses, sublingually or once a month by the parenteral route. 
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Adverse effects 
Rarely nausea, vomiting and rhinitis have been reported with the intra nasal 
formulation. 
 
Erythropoietin and Darbepoetin 
Erythropoietin is a glycoprotein normally secreted by the kidneys that  
regulates red blood cell proliferation and differentiation in bone marrow. Human 
erythropoietin is produced by rDNA technology, is effective in the treatment of 
anaemia caused by renal disease, anaemia associated with HIV and in some cancer 
patients. Darbepoetin is a long acting version of erythropoietin that has two 
carbohydrate chains which improves its biological activity and half-life is increased 
about three times that of erythropoietin and it shows decreasedclearance. 
 
Adverse effects 
Cause elevated blood pressure and arthralgia in some cases. When 
erythropoietin is used to target haemoglobin concentration more than 12g/dl serious 
cardiovascular events such as (thrombosis and severe hypertension), increased risk of 
death, shortened time of tumour progression and decreased survival has been 
observed. 
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HAEMOPOIESIS10 
Haemopoiesis or hematopoiesis is the process of the origin, development and 
maturation of all the blood cells. 
 
 
 
Fig.1.1 HAEMOPOISIS 
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 BLOOD  
Blood is the connective tissue in fluid form . it is considered as the fluid of life because it 
carries oxygen from the lungs to all parsts of the body and carbon di oxide from all parts of the 
body to the lungs. It is also known as fluid of gowth because it carries nutritive substance from 
the digestive system and the hormones from the endocrine gland to all the tissues . The blood is 
also called as the fluid of health because it protects the body against the disease and get rid of the 
waste products and unwanted substances by transporting them to  the excretory organs like 
kidneys.  
 
BLOOD CELLS  
THREE TPYES OF CELLS PRESENT IN BLOOD  
 Red blood cells or Erythrocytes 
 White blood cells or Leukocytes 
 Platelets or Thrombocytes  
PROPERTIES OF BLOOD  
COLOUR  
Blood is red in colour . Arterial blood is scarlet red because it contains more oxygen and 
venous blood is purple red because of more carbon dioxide. 
VOLUME 
The average volume of blood in a normal adult is 5 litres. In new born baby it is 450ml. It 
increases during growth and reaches 5 litres at the time of puberty. In female it is slightly less 
and is about 4.5 litres. It is about 8 % of the body weight in a normal young healthy adult 
weighing about 70Kg. 
pH  
Blood is slightly alkaline and its Ph in normal conditions is 7.4. 
 
SPECIFIC GRAVITY  
 The specific gravity of Total Blood: 1.052 to 1. 061  
 The specific gravity of Blood cells: 1.092 to 1.101  
                                                                              Introduction 
 
Department of Pharmacognosy, MMC, Chennai-3 Page 13 
 
 The  specific gravity of Plasma :  1.022 to 1.026  
 
VISCOSITY 
Blood is five times more viscous than water. It is mainly due to red blood cells and 
plasma proteins. 
 
FUNCTIONS OF BLOOD 
 NUTRIENT FUNCTION:  
Nutrient substance like glucose,amino acids lipids and vitamins derived from 
digested food are absorbed from gastrointestinal tract and carried by blood to different 
parts of the body for growth and production of energy. 
 RESPIRATORY FUNCTION: 
Blood carries oxygen from alveoli of lungs to different tissues and carbon 
dioxide from tissues to alveoli. 
 EXCRETORY FUNCTION: 
Waste products formed from metabolic activities are removed by blood and 
carried out to the excretory organs like kidneys, skin, liver, etc. for excretion. 
 TRANSPORT OF HORMONES AND ENZYMES: 
Endocrine hormones are released directly into blood .The blood transport these 
hormones to their target organs or tissues. Blood also transport enzymes. 
 REGULATION OF WATER BALANCE: 
Water content of the blood is freely interchangeable with interstitial fluid. This 
helps in regulation of water content of the body 
 REGULATION OF ACID BASE BALANCE: 
The plasma proteins and haemoglobin acts as buffers and help in regulation of  
acid base balance. 
 REGULATION OF BODY TEMPERATURE: 
Blood is responsible for maintaining the thermo regulatory mechanism in the 
body since the blood has high specific heat. 
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STORAGE FUNCTION: 
Water, glucose , proteins , sodium , potassium are constantly required by the tissue . And 
these are taken from the blood during the conditions like starvation, fluid loss , electrolyte loss , 
etc. 
DEFENSIVE FUNCTION: 
Neutrophils and monocytes in the blood engulf the bacteria by phagocytosis . 
Lymphoctyes are involved in development of immunity. Eosinophils are responsible for 
detoxification  disintegraton and removal of foreign proteins. 
RED BLOOD CELLS  
Red blood cells are non nucleated formed elements of blood. Red blood cells are known 
as erythrocytes. The red colour of RBC is due to the presence of the colouring pigment called 
haemoglobin . RBC plays a vital role in transport of respiratory gases. RBCs are larger in 
numbers compared to the other two cells namely white blood cells and platelets. 
NORMAL VALUE 
The RBC count ranges between 4to5.5 million/cu mm of blood. In adult males it is 5 
million/cu mm and in adult females it is 4.5 million/cu mm. 
NORMAL SHAPE  
RBCs are disc shaped [bioconcave] , the central portion is thinner and periphery is 
thicker . The bioconcave  contour of RBCs has some mechanical and functional advantages.  
NORMAL SIZE  
Diameter         : 7.2µ(6.9-7.4 µ) 
Surface area    : 120 sq µ 
Volume           : 85-90 cu µ 
 
HAEMOGLOBIN  
Haemoglobin [Hb] is the iron containing colouring matter of RBC. It is a chromoprotein 
forming 95% of dry weight of RBC and 30 to 34% of wet weight. The function of haemoglobin 
is to carry the respiratory gases, and carbon di oxide . It also acts as buffer. 
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NORMAL HAEMOGLOBIN 
Average haemoglobin content in blood is 14 to 16g/dl. However, the value varies 
depending upon the age and the sex of the individual. 
STRUCTURE OF HAEMOGLOBIN 
Haemoglobin is a conjugated protein .It consists of a protein combined with an iron containing 
pigment . The protein part is globin and the iron containing pigment is heme. Iron is converted to 
stable ferric [Fe+++] state which is attached to N-of the each pyrole ring and N-of the globin 
molecule.  
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2. Review of Literature 
 
 
 
Karwasra Ret al studied the Safety assessment and attenuation of cisplatin induced 
nephrotoxicity by tuberous roots of Boerhaaviadiffusa.  The findings of the work  indicated  
that Boerhaavia diffusa was effective in mitigating cisplatin-induced nephrotoxicity in rats  and 
thus, for  that the acute and sub-acute toxicity studies conducted to evaluate the safety profile 
of Boerhaavia diffusa. The no-observed adverse effect level of tuberous roots 
of Boerhaavia diffusa root extract was 1000 mg/kg. 
 
Saraswati S et al worked on the title,Punarnavine, an alkaloid 
from Boerhaavia diffusa exhibits anti-angiogenic activity via downregulation of VEGF in 
vitro and in vivo.they reported that Punarnavine, a quinolizidine alkaloid isolated 
from Boerhaavia diffusa  possess analgesic, anti-inflammatory, hepato-protective, 
immunomodulatory and anti-proliferative properties. 
 
Bairwa K et al, stated thatRotenoids from Boerhaavia diffusa function  as potential anti-
inflammatory agents.The study concluded that the rotenoids  exhibited significant anti-
inflammatory activity (56.6% at 50 mg/kg) when evaluated in an in vivo carrageenan-induced rat  
paw model. 
 
Manjrekar PN et al, have done a  Comparative studies of the immunomodulatory activity 
of Tinospora cordifolia and Tinospora sinensis. The study was carried out in the following 
manner. The water and ethanol extracts of stems of Tinospora cordifolia and T. sinensis inhibited 
immunosuppression produced by cyclophosphamide. Ethanol extracts of stems of both the plants 
inhibit cyclophosphamide-induced anemia.  
 
Maurya et al worked on theConstituents of Tinospora sinensis and their antileishmania 
activity against Leishmania donovani.Their work  proved that there were some compounds 
isolated from the plants exhibited the highest in vitro antileishmanial activity against Leishmania 
donovani promastigotes and intracellular amastigotes. 
 
Layeeq Set al processed on Clinical efficacy of Amalaki Rasayana in the management of 
Pandu (Iron deficiency anemia). They conducted a randomized open  clinical trial. Iron 
deficient anemic patients (n = 25) having Hb <12g% in females and 13g% in males and S.Iron 
<50mg/dl were selected and divided into two groups. Group A was given 2 g of Amalaki 
Rasayana thrice a day with unequal quantity of honey and ghee for 45 days, while Group B was 
given 150 mg ferrous fumarate + 1500 mcg folic acid (standard control) once a day with water 
for 45 days. Assessment was done on the basis of relief in cardinal symptoms of Pandu and 
hematological parameters.it was reported  that  On hematological parameters statistically 
significant increase was found in mean corpuscular volume and mean corpuscular hemoglobin. 
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Tahir I et al, worked on theEvaluation of phytochemicals, antioxidant activity and 
amelioration of pulmonary fibrosis with Phyllanthus emblica leaves. They examined  the 
antioxidant potential of a methanol extract of Phyllanthus emblica leaves (PELE) by in vitro 
methods as well as by an in vivo animal model, along with HPLC-DAD screening for phyto-
constituents. It was reported that  PELE exhibited an appreciable in vitro antioxidant activity and 
scavenged the DPPH radical (IC50  =  39.73  ±  2.12 μg/mL) and nitric oxide 
(IC50  =  39.14  ±  2.31 μg/mL) while for anti-lipid peroxidation moderate antioxidant activity 
was noticed. 
Thenmozhi AJet al studied  on the title,Tannoid principles of Emblica officinalis attenuated 
aluminium chloride induced apoptosis by suppressing oxidative stress and tau pathology via 
Akt/GSK-3βsignaling pathway. The work indicated the neuroprotective effect of tannoids 
principles of Emblica officinalis (EoT) against memory loss caused by aluminium chloride 
(AlCl3) intoxication. It was concluded that administration of EoT nullified the cognitive deficits, 
biochemical abnormalities and apoptosis induced by AlCl3 treatment. Moreover EoT prevents 
tau hyperphosphorylation by targeting the GSK-3β/Akt signaling pathway. 
 
Karim NA et al insisted on the topicMoringa oleifera Lam: Targeting Chemoprevention. 
They poposed that  Chemopreventive effects of M. oleifera are expected due to the existence of 
glucosinolate which  is reported to have the ability to induce apoptosis in anticancer studies. 
They also highlighted the advantages of M. oleifera targeting chemoprevention where 
glucosinolates could help to slow the process of carcinogenesis through several molecular 
targets. It  also includes inhibition of carcinogen activation and induction of carcinogen 
detoxification, anti-inflammatory, anti-tumor cell proliferation, induction of apoptosis and 
inhibition of tumor angiogenesis. 
 
Surendra TV et. al., worked on the heading  RSM optimized Moringa oleifera peel extract 
for green synthesis of M. oleifera capped palladium nanoparticles with antibacterial and 
hemolytic property. The work established that  M. oleifera capped Pd nanoparticles were 
synthesized by  microwave assisted methanolic extract of M. oleifera peel. The better optimized 
conditions for the extraction was found as 400W, 25mL of CH3OH at 65°C for 2min. They  
observed 61.66mg of extract yield from this method. Eco-friendly M. oleifera capped Pd NPs 
were synthesized using M. oleifera peel extract and confirmed using the different 
characterization techniques like UV- Vis spectroscopy, XRD, SEM and HR-TEM analysis. They  
found the size of the M.oleifera capped Pd NPs nanoparticles as 27±2nm and shape of the 
particles as spherical through the TEM analysis. M.oleifera capped Pd NPs exhibits good 
antibacterial activity against S. aureus (Staphylococcus aureus) and E. coli (Escherichia coli) 
bacterial strains and we found the zone inhibition as 0.6 and 0.7mm. The synthesized 
M. oleifera capped Pd NPs are screened for hemolytic activity and it proved the 
M. oleifera capped Pd NPs are non-toxic on RBCs cells. 
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Karthivashan G, et al worked on The modulatory effect of Moringa oleifera leaf extract on 
endogenous antioxidant systems and inflammatory markers in an acetaminophen-induced 
nephrotoxic mice model.In the study, they  evaluated the nephro-protective potential of 
Moringa oleifera  leaf extract against  N-Acetyl-p-Aminophenol, also known as acetaminophen. 
Moringa Oleifera  leaf extract has demonstrated  therapeutic effectiveness against acetaminophen 
induced nephrotoxicity through enhancement of the endogenous antioxidant system and a 
modulatory effect on specific inflammatory cytokines in kidney tissues. 
 
Dungca NT proved the Protective effect of the methanolic leaf extract of Eclipta alba (L.) 
Hassk. (Asteraceae) against gentamicin-induced nephrotoxicity in Sprague Dawley rats. The 
extract protected the rat kidneys against gentamicin-induced renal tubular alterations and rises in 
blood urea nitrogen, serum creatinine, and microprotein levels. Lipid peroxidation and decrement 
in catalase levels were also ameliorated. The study revealed the protective effect of the 
methanolic leaf extract of E. alba and suggests that the probable mechanism for the 
nephroprotection by the extract may be due to its good radical scavenging activity and Fe(3+) 
ion-reducing ability. 
 Arya et al studied on the title  Anti-breast tumor activity of Eclipta extract in-vitro and in-
vivo: novel evidence of endoplasmic reticulum specific localization of Hsp60 during apoptosis. 
They worked on the  bio-guided fractionation of Eclipta alba extract and discovered that 
particularly the chloroform fraction of Ecliptaalba  is selectively inducing cytotoxicity to breast 
cancer cells over non-tumorigenic breast epithelial cells. LC-MS approach identified that luteolin 
is mainly attributed for its anti-cancer activities. Moreover, oral administration of CFEA not only 
offers potential anti-breast cancer effects in-vivo but also mitigates tumor induced hepato-renal 
toxicity. Together, the  study  offered  novel mechanistic insight into the CFEA mediated 
inhibition of breast cancer and may potentially open up new avenues for further translational 
research. 
Mahar Set.al., studied on  Haemostatic effect of eclipta alba on albino rabbits.In the present 
study ethanolic leaf extract of eclipta alba was evaluated for its haemostatic activity by their 
ability to affect the screening test or modify the experimentally induced prolongation of test time 
on the basis of its folklore claim in normal, aspirin and heparin treated rabbits. The parameters 
recorded were BT, CT, PT and APTT & platelet count in all the three groups. The study was 
carried out in 3 parts in different doses 200,400,600 & 800mg/kg. Part-A-study of the 
haemostatic effect of Ethanolic extract of E.alba (EEEA) in graded doses on normal rabbits. Part-
B-study of EEEA in aspirin treated rabbits. Part-C-study of EEEA in heparin treated rabbits. 
Tranexamic acid was used as the standard drug. Eclipta alba  demonstrated to have anti-
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haemorrhagic activity against snake bite not affecting any coagulation factor. No significant 
effect on PT, APPT and platelet count was observed. EEEA exhibited definite haemostatic effect 
in the above 3 sets of study.  
 
Molla SH et.al  work revealed anthelmintic effects of M. koenigii on Haemonchus contortus.It 
was evident from their paralytic condition and/or death at eight hour post exposure in different 
concentrations (12.5, 25, 50 mg/ml) of aqueous and methanolic extracts which were dose-
dependent. Aqueous and methanolic extracts of M. koenigii were found to have low percent 
inhibitory effect on egg hatching but showed significant anthelmintic activity. 
16.Nollu.B et.al.,studied the effect of M.koenigii leaves in the inhibition of  26S  proteasome and 
its apoptotic action in vivo in a xenograft tumor mouse model . Analysis of the extract revealed 
the presence of flavonoid compounds which act as proteasome inhibitors. The literature reported 
that : Quercetin, Apigenin, Kaempferol and  Rutin; flavonoids present in the leaf extract, dose-
dependently inhibited the endogenous 26S proteasome activity in MDA-MB-231 cells. 
Reduction in tumor growth was associated with a decrease in proteasomal enzyme activities in 
the treated groups. 
Ramasamy et.al.,  reported that, the hydro-alcoholic extract of Murraya koenigii leaves 
possesses significant anti-diarrheal activity due to its inhibitory effect on gastrointestinal 
motility, making it useful for a wide number of gastrointestinal diseases.
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3. RATIONAL FOR SELECTION 
 
 
The more technical we grow, the much we get to know about the immense importance of 
our Indigenous herbs in the treatment of various ailments. Being a student of this era, I was 
curious in finding out the hidden disorder or disease that needs to be much studied. One such 
disease, that is prevalent in many, irrespective of age (younger/adults/older) is anaemia.Having 
many inbuilt metabolism to deal with blood and blood loss i.e the menstrual cycle and 
pregnancy, female are most commonly affected by anaemia. 
 
Herbs are gaining much  importance in treating the diseases. The growing herbal market 
makes the polyherbal formulations an evoking trend! Developing therapeutic agents from natural 
products has renewed the world wide attention and stimulated new wave of research on the 
benefits of Herbal Medicine as an effective alternative therapy tool for various illness.When it 
comes to a polyherbal formulation, the herbs used in it should be popular. They would have 
gained much trust among the folk and at the same time be economical and affordable. 
Taking into consideration the above parameters the following herbs were chosen. 
 Boerhavia diffusa(Roots) 
 Eclipta prostrate (Leaves) 
 Murraya koenigii(Leaves ) 
 Moringa oleifera (Leaves ) 
 Phyllanthus embelica(Fruit pulp) 
 Tinospora sinensis(Stem) 
 
The hexa herbs chosen have many Etho-medicinal application and traditional claims. 
They are employed in numerous ayurvedic formulations and are marketed successfully. 
They all have the traditional claim to be helpful in aneamia. Giving them in a combination, 
would promisingly exhibit   synergistic action. 
Thus the present study was designed completely, to  formulate a polyherbal haematinic  
capsule and helpout the womenhood live a happy healthy life!    
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4. AIM AND OBJECTIVE 
 
The aim of the present work is to develop a polyherbal haematinic capsules from the 
selected plant materials and evaluate the same.  
 The objectives are selection of the plant material followed by, 
 
                                                                         Continuous Hot Percolation of the various parts                           
                                                                          of the plants chosen using Ethanol as the solvent. 
 
 
 
                                                                           To perform the various  phytochemical studies.  
 
 
 
                                                                         Evaluation of anti-anaemic activity of the extracts.    
 
 
 
 
 
                                                                            Formulation of  polyherbal haematinic capsules.       
 
 
 
 
                                                                          Evaluation of the formulated capsules. 
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5. PLANT PROFILE 
Boerhavia  diffusa
( 28,29) 
A very variable, diffusely branched, pubescent or glabrous, prostrate herb, abundantly occurring 
as a weed throughout India. 
Synonym: Spreading Hog weed 
 
 
                     Fig.5.1Boerhavia  diffusa 
 
Common name: Punarnava 
Vernacular names 
Bengali: Gadhapurna, Punarnaba                                   
Gujarati: Satodi 
Hindi: Biskhafra 
Kannada: Bala-vadikae 
Malayalam: Thumizhazhma 
Marathi: Raktavasu 
Sanskrit: Punarnavam 
Tamil: Mukku-rattai 
Telugu: Atikamamidi 
DISTRIBUTION 
Found throughout India 
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                                               Fig.5.2Boerhavia  diffusa 
 
PLANT TAXONOMY
(30) 
Kingdom          :Plantae 
Phylum             :Angiosperms 
Class                 :Eudicots 
Order                 :Caryophyllales 
Family               :Nyctaginaceae 
Genus               : Boerhavia 
Species               : diffusa 
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PLANT DESCRIPTION 
ROOT 
Stock stout, fusiform,woody 
STEMS 
Creeping, often purplish, swollen at the nodes, upto 1.2m long 
LEAVES 
Long-petioled, ovate or oblong – cordate, entire or sinuate, usually whitish  and smmoth beneath 
and rough green on upper surface. 
FLOWERS 
Red, pink or white, in small umbels arranged in axillary and terminal panicles 
FRUITS 
Ovate, oblong, pubescent, five-ribbed, viscid, glandular anthocarps            
 
FLOWERING AND FRUITING 
 Throughout the year 
TASTE                                                                          
Bitter 
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                                                  Fig.5.3 Boerhavia  diffusa 
 
Eclipta prostrata  
(31,32) 
A small genus of herbs, distributed in the tropical and sub-tropical regions of  the world. One 
species occurs in India. 
Synonym : Eclipta alba 
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Fig.5.4 Eclipta alba 
Vernacular names 
Bengali - Kesuti 
Gujarati- Bhangra 
Hindi - Bhangra 
Kannada- Garagadasoppu 
Malayalam- Kyonni 
Marathi- Bhringuraja 
Sanskrit- Bhringaraja, kesaraja 
Tamil- Garuga, kayanthakara 
Telugu- Galagara 
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                                                          Fig.5.5 Eclipta alba 
DISTRIBUTION 
Distributed throughout India 
HABITAT 
Found in moist areas, waste places and road sides. The plant shows variations in 
habit in different habitats, in dry and rocky habitats, it reduces in size. 
DESCRIPTION 
An erect or prostrate, much branched, strigosely  hirsuate, annual, often rooting at the nodes. 
LEAVES 
 opposite, sessile, oblong, lanceolate, 1-4 inch long 
FLOWERS 
Head white, 0.25 to 0.35 inch in diameter 
 
                                                                         Plants Profile 
 
 
 
Department of Pharmacognosy, MMC, Chennai-3 Page 29 
  
 
  
 
                                                      Fig.5.6 Eclipta alba 
 
 
PLANT TAXONOMY
(33)
 
Kingdom: Plantae 
Subkingdom: Tracheobionta 
Division: Magnoliophyta 
Class: Magnoliopsida 
Subclass: Asteridae 
Order: Asterales 
Family: Asteraceae 
Genus: Eclipta 
Species: prostrata 
FLOWERING AND FRUITING 
Throughout the year 
TASTE 
Bitter 
ETHNO-MEDICINAL USE 
ROOT 
Snake bite, applied externally as antiseptic in ulcer, emetic and purgative. 
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LEAF 
Fever , malaria, conjunctivitis, scorpion sting, gastric problem, skin disease, ulcer, dysentery, 
blood purifier, diarrhea, dysentery, wound, elephantiasis. 
WHOLE  PLANT 
Anodyne and absorbent, rubbed on gums in tooth ache.   
 
ETHNO-MEDICINAL USE 
ROOT 
Diarrhea, dysentery, diabetes 
LEAF 
Fever, headache, piles, joint pain, diabetes, gastric trouble. 
STEM 
Skin diseases, jaundice, stomachic, asthma, abdominal gripes, diphtheria, cough, leprosy and 
snake bite, joint diseases, fever, jaundice, dysentery , malaria, diarrhoea, ulcers, swelling.  
WHOLE PLANT 
Bone fracture, piles, fever, jaundice. 
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Moringaoleifera
(34,35) 
A small genus of quick-growing trees distributed in India, Arabia, Asia Minor, Africa. 
Two species are recorded from India , of which one, M.oleifera, is widely cultivated in the 
tropics  for  its edible fruits. 
SYNONYM: Moringa pterygosperma 
 
 
 
                                               Fig.5.7Moringaoleifera 
 
COMMON NAME: Drumstick tree, Radish Tree. 
VERNACULAR NAMES 
Sanskrit: Shobhanjana 
Hindi: Mungna, sainjna, shajna 
Bengali: Sajina 
Marathi: Achajhada, Shevgi 
Gujarati: Midhosaragavo, Saragavo 
Telugu: Mulaga, muga, tellamunga 
Tamil: Murungai 
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Kanada: Nugge 
Malayalam: Murima, sigru, moringa 
Assam: Saijna, sohjna. 
PLANT TAXONOMY
(36) 
Kingdom :Plantae 
Phylum: Angiosperms 
Class : Mangoliopsida 
Order :  Brassicales 
Family : Moringaceae 
Genus :Moringa 
Species:  oleifera 
DISTRIBUTION 
Found wild in the sub-Himalayan tract ,from Chenab eastwards to Sarda, and  cultivated all over 
the plains of India 
PLANT DESCRIPTION 
A small  or medium-sized tree, about 10m. high,. 
BARK: Thick, soft, corky, deeply fissured, young parts tomentose. 
LEAVES:  Tri-pinnate 
LEAFLETS:  Elliptic  
FLOWERS: White, fragrant, in large panicles 
PODS:  Pendulous, greenish, 22.5-50.0cm or more in length, triangular, ribbed 
SEEDS: Trigonous with wings on angles. 
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                                                        Fig.5.8 MoringaoleiferaFlower 
FLOWERING AND FRUITING 
Almost throughout the year. 
 
 
 
 Fig.5.9 MoringaoleiferaLeaf Powder 
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ETHNO-MEDICINAL USE 
ROOT- Rheumatism, asthma, liver complaint, Paralysis, epilepsies, scorpion bite, snlae bite, 
tooth ache, astringent   
GUM- Ear complaint 
BARK- Stomach trouble, fever, eczema, typhoid, boils, toothache, poisonous bites, rheumatism 
LEAF- Scurvy, wound , night blindness, diarrhea, dysentery, cough, cold, diseases of liver, 
spleen. 
FLOWERS- Eye ailments 
PODS- Eye ailments, diseases of  Liver, spleen. 
SEED- Indigestion, Seed oil in Gout, Rheumatism. 
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Murraya koenigii
(35,36) 
Synonym: Bergera koenigi 
Common names: Curry leaf tree.  
 
 
                                                            Fig.5.10Murraya koenigii 
 
Vernacular names 
Tamil:  karuveppilei 
Hindi: kathnim, gandhela, barsanga. 
Bengali: barsanga, kariaphulli. 
Marati: karhinimb,  gandla, jhirang. 
Gujarati: goranimb, kadhilimbdo 
Telugu: karepaku 
Kannada: karibevu 
Malayalam: kariveppilei 
Oriya: barsan, basango 
DISTRIBUTION 
Distributed from South and East Asia to Australia . 
In India cultivated in Tamil Nadu, Maharashtra, and North India.Especially in konkan, W.ghats, 
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along the foot of the Himalaya from Kumaon to Sikkim.
 
 
                                          Fig.5.11Murraya koenigii 
 
PLANT TAXONOMY
(37)
 
Kingdom:  Plantae 
Phylum: Spermatophyta 
  Class: Magnoliospida 
  Order: Sapindales 
 Family: Rutaceae 
 Genus: Murraya 
Species: koenigii 
FLOWERING AND FRUITING 
February – April. 
TASTE:  
PLANT  DESCRIPTION  
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A  handsome, aromatic, more or less deciduous shrub or small tree. 
Leaves: Imparipinnate,strongly aromatic. 
Leaflets: 9-25,ovate, lanceolate, dentate, oblique base, almost glabrous above, pubescent beneath 
Flowers: terminal corymbose cymes, white in colour, have characteristic fragrance. 
Berries: ellipsoid or sub-globose, purplish black when ripe, 2 seeded. 
 
 
 
ETHNO-MEDICINAL USE 
ROOT 
Tonic, stomachic, carminative, Juice of root used in relieving renal pain 
LEAF 
used internally in diarrhea, spasmolytic, appetizer, externally for bruises and eruptions, tonic. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.5.12 Murraya koenigii 
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Phyllanthus embelica  
(38,39) 
Synonym:Emblica officinalis, Emblic Myrobalan, Indian Gooseberry 
Common names: Amla 
 
                                           Fig.5.13 Phyllanthus embelica   
 
Vernacular names
 
Bengali- Amla 
Gujarati- Amali, ambala 
Hindi- Amla, amlika, aonla 
Kannada- Amalakas 
Malayalam- Nelli 
Sanskrit- Adiphala, dhatri, amalaka 
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Tamil-Nelli 
Telugu- Amlakamu 
DISTRIBUTION
 
Native of India, Ceylon, Malaya, China 
 
                                         Fig.5.14 Phyllanthus embelica   
PLANT TAXONOMY
(40) 
KINGDOM:Plantae 
PHYLUM: Tracheophyta 
CLASS: Magnoliopsida 
ORDER:Euphorbiales 
FAMILY:Euphorbiaceae 
GENUS:Phyllanthus 
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SPECIES:embelica 
FLOWERING AND FRUITING
 
February - April 
TASTE: Sweet, sour, astringent  
 
 
                                           Fig.5.15 Phyllanthus embelica Fruits 
 
 
ETHNO-MEDICINAL USE
 
ROOT 
 
Diarrohoea, gonorrhea, jaundice. 
LEAF 
Conjuctivitis, diaarhoea, dysentery, dyspepsia, inflammation 
FRUITS 
Anaemia, asthma, bronchitis, colic, cough, diabetes, diarrheoa, dysentery, dyspepsia, fever, 
flatulence,  haemorrhages, inflammation, jaundice, leprosy, leucorrhoea, menorrhagia, peptic 
ulcer, skin medicine.   
SEEDS
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Asthma, bronchitis, menstrual trouble. 
 
Tinospora sinenisis 
(41,42) 
A genus of  deciduous woody climbers, distributed in the tropics of Asia, Africa, and Australia. 
Three species ouucr in India. 
Synonym:Tinospora malabarica, Tinospora tomentosa 
 
                   Fig.5.16 Tinospora sinenisis 
Common names : Guduchi 
Vernacular names 
Bengali: Podmo gulancha 
Gujarati: Gado 
Hindi: Gileo, gulcha 
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Kannada: Sudarsna-balli 
Malayalam : Amrytu  
Marathi: Gulvel  
Sanskrit: Amrita 
Tamil: Seenthil kodi 
Telugu: Tippateege 
 
 
                                                      Fig.5.17 Tinospora sinenisis 
DISTRIBUTION 
Throughout tropical India 
 
PLANT TAXONOMY
 (43) 
KINGDOM: Plantae 
PHYLUM: Tracheophyta 
CLASS: Mangoliopsida 
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ORDER: Ranunculales 
FAMILY:Menispermaceae 
GENUS: Tinospora 
SPECIES: sinensis 
 
                            Fig.5.18 Tinospora sinenisis 
 
FLOWERING AND FRUITING 
December-June 
TASTE: Bitter 
ETHNO-MEDICINAL USE 
ROOT 
Diaarhoea, Diabetes,diabetes 
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LEAF 
Head ache, fever, piles, joint pain, gastric trouble 
 
STEM 
Skin disease, jaundice, stomachic, asthma, diphtheria, cough, leprosy, jaundice, ulcers, diarrhea, 
malaria, snake bite. 
 
WHOLE  PLANT 
Bone,fracture, piles, fever, jaundice. 
 
 
 
Fig.5.19 Tinospora sinenisis 
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6. PLAN OF WORK 
 
 
 PLANT COLLECTION  
 AUTHENTICATION 
 PREPARATION OF HERBARIUM 
 PREPARATION OF EXTRACTS. 
PRELIMINARY QUALITY CONTROL OF THE RAW MATERIALS 
1)LOSS ON DRYING 
2)DETERMINATION OF ASH VALUES 
 Total ash 
 Water soluble ash 
 Acid insoluble ash 
 Sulphated ash 
3) DETRMINATION OF EXTRACTIVE VALUES 
 Water soluble extractive value 
 Alcohol soluble extractive value 
 Ether soluble extractive value 
4) FLUORESCENCE ANALYSIS  
5) QUALITATIVE PHYTOCHEMICAL STUDIES OF THE POWDER AND EXTRACTS 
CHROMATOGRAPHICANALYSIS  
 
 TLC of all plantsextract 
 HPTLC of combinedextract 
 
 
QUANTITATIVEANALYSIS 
 Estimation of Totalalkaloids 
 Estimation of Total phenolicconstituents 
 Estimation ofFlavonoids 
 Estimation of Ironcontent 
 Estimation of heavy metals 
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 PRE FORMULATIONAL STUDIES 
 
 Bulk density 
 Tapped density 
 Compressibility index 
 Hausner’s ratio 
 Angle of repose. 
 
DEVELOPMENT OF FORMULATION 
 
 
PHARMACEUTICAL EVALUATION 
 Uniform Weight  
 Disintergration test 
 pH 
 
PHARMACOLOGICALSTUDIES 
 Evaluation of Anti-anaemicactivity 
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7. METHODOLOGY 
 
Polyherbal haematinic capsules , consists of six herbs viz., Boerhavia diffusa,(roots) Eclipta 
prostrata,(leaves) Moringa oleifera, (leaves) Murraya koenigii, (leaves) Phyllanthus 
embelica (fruit pilp), Tinospora cordifolia.(stems).  
 
PLANT COLLECTION 
As the plants selected were all available in and around the locality, they were collected in 
person from the respective places mentioned below, during the Months of JUNE-JULY, 
2017. 
                                               Table 7.1Plant Collection Details 
Name of the plant Place 
Boerhavvia diffusa Dhindivanam, Tamil Nadu 
Eclipta prostrata Dhindivanam, Tamil Nadu 
Moringa oleifera Chennai, Tamil Nadu 
Murraya koenigii Nagapattinam, Tamil Nadu 
Phyllanthus embelica Dhindivanam, Tamil Nadu 
Tinospora cordifolia Dhindivanam, Tamil Nadu 
 
AUTHENTICATION 
The collected plants were authenticated in the “ SIDDHA CENTRAL RESEARCH 
INSTITUTE” , Arumbakkam, Chennai-600106, by  P.Sathiyarajeswaran, Assistant Director 
Incharge and Sasikala Ethirajulu, Consultant(Pharmacognosy) .  
 
PLANT  MATERIALS 
 
The procured plant materials were washed thrice in running water, and cleaned thoroughly. 
They were then dried under shade for a week or so. Once they were completely dried, they 
were ground into coarse powder and stored in air tight containers and preserved for the 
further processing. 
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PHYSIO-CHEMICAL CONSTANTS
44-46 
 Shade dried powdered plant materials of the plants, Boerhavia diffusa,(roots) Eclipta 
prostrata,(leaves) Moringa oleifera, (leaves) Murraya koenigii, (leaves) Phyllanthus 
embelica (fruit pilp), Tinospora cordifolia.(stems),used for the determination of the physio 
chemical constants in accordance with the WHO guidelines. 
DETRMINATION OF ASH VALUES 
 Ash values are helpful in determining the quality and purity of a crude drug in the 
powdered form. The residue remaining after incarnation is the ash content of the drug, which 
simply represents inorganic salts, naturally occurring drug or adhering to it or delibility 
added to it, as a form of adulteration. 
 Ash value of a crude drug is defined as the inorganic residue remaining after 
incineration, which complies of inorganic salts, naturally occurring in drug or adhering to it 
or deliberately added to it as a form of adulteration. Hence it is used for the determination of 
the quality and purity of the crude drug in the powdered form.  
TOTAL ASH: 
 Total ash method is designed to measure the total amount of material remaining after 
ignition.  They include both physiological ash which is derived from plant tissue itself and 
non-physiological ash which is the residue of extraneous matter adhering to the plant 
surface. 
Procedure:  
 Silica crucible was heated to red hot for 30 minutes and cooled in the desiccators 
Incinerate about 2 to 3 g accurately weighed, of the ground drug in a tarred silica dish at a 
temperature not exceeding 450
0
c  until the sample is free from carbon, cooled in desiccators 
and weighed. The ash obtained was weighed. The percentage of total ash was calculated.  
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WATER SOLUBLE ASH: 
The difference in weight between the total ash and the residue after treatment of the total ash 
in water.  
Procedure: 
 Total ash obtained is boiled for 5 minutes with 25 ml of water, insoluble matter were 
collected in a ashless filter paper, washed with hot water and ignite for 15 min at a 
temperature not exceeding 450
0
.  Subtract the weight of this residue in mg from the weight 
of total ash. Calculate the content of water-soluble ash in mg per gram of air-dried material.  
   Water soluble ash =  Weight of residue obtained    X 100 
      Weight of the sample taken  
ACID INSOLUBLE ASH: 
 The residue obtained after boiling the total ash with dilute hydrochloric acid, the 
remaining insoluble matters are ignited and measured. This measures the amount of silica 
present, especially as sand and siliceous earth.  
Procedure:  
 To the crucible containing total ash of the sample, 25 ml of dilute hydrochloric acid 
is added. The insoluble matter is collected on an ashless filter paper (Whatman 41) and 
washed with hot water until the filtrate is neutral.  Filter paper containing the insoluble 
matter to the original crucible, dry on hot plate and ignite to constant weight. Allow the 
residue to cool in a suitable desiccators for 30 minutes and weighed without delay. Content 
of acid-insoluble ash with reference to the air dried drug is calculated. 
  Acid insoluble ash =  Weight of the residue obtained    X 100 
     Weight of the sample taken  
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SULPHATED ASH 
 Sulphated ash test is used to measure the amount of residual substance not volatilized 
from a sample. These test are usually used to determine the content of inorganic substance.  
Procedure:  
 Silica crucible are heated to redness for 10 minutes, allowed to cool in a desiccator 
and weigh. 2 g of sample were accurately weighed, ignited gently then thoroughly chared. 
Cool, moistened the residue with 1 ml of sulphuric acid, heat gently until the white fumes are 
no longer evolved and ignite at 800 ± 25
o
 until all black particles have disappeared. Crucible 
are allowed to cool,  add few drops of sulphuric acid and heat. Ignite as before, allow to cool 
and weigh. This process is repeated until two successive weighing differ by more than 0.5 
mg.  
 Sulphated ash = weight of the residue obtained X 100 
   Weight of the sample taken 
DETERMINATION OF EXTRACTIVE VALUES: 
 Extractive values are useful for the evaluation of phyto constituents especially when 
the constituents of a drug cannot be readily estimated by any other means. Further these 
values indicate the nature of the active constituents present in a crude drug. 
 
Determination of water soluble extractive 
                     5gm of air dried coarsely powdered sample was weighed and macerated with 
100ml of chloroform water (95ml distilled water and 5ml chloroform) in a closed flask for 
24 hours. It was shaken frequently for six hours and allowed to stand for rest eighteen hours. 
It was then filtered rapidly, taking precautions against loss of solvent and 25ml of the filtrate 
was evaporated to dryness in a tarred flat bottomed shallow dish and was dried at 105°C for 
1 hour in the hot air oven and cooled in desiccators for 30min and weighed. The process was 
repeated till a constant weight was obtained; the percentage of water soluble extractive value 
was calculated with reference to the air dried drug. 
    Water soluble extractive value =  weight of the dried extract   X   100 
 weight of the sample taken 
 
 
 
 
Methodology 
 
Department of Pharmacognosy, MMC, Chennai-3 Page 50  
Determination of alcohol soluble extractive 
                           5gm of the coarsely powdered sample was weighed and macerated with 
100ml 90% ethanol in a closed flask for 24 hours. It was shaken frequently for six hours and 
allowed to stand for eighteen hours. It was then filtered rapidly, taking precautions against 
loss of solvent and 25ml of the filtrate was evaporated to dryness in a tarred flat bottomed 
shallow dish. It was dried at 105°C for 1hour in a hot air oven. The dish was cooled in 
desiccator and weighed. The process was repeated till the constant weight was obtained. The 
percentage of alcohol soluble extractive value with reference to the air dried drug was 
calculated. 
      Alcohol soluble extractive =  weight of the dried extract  X 100 
 weight of the sample taken  
 
Determination of non volatile ether soluble extractive (fixed oil content) 
                     A suitably weighed quantity of the sample was transferred to an extraction 
thimble and extracted with solvent ether or petroleum ether (Boiling Point 40 - 60°C) in a 
Soxhlet for 6 hours. The extract was filtered into a tarred evaporating dish, evaporated and 
dried at 105°C to constant weight. The percentage of non volatile ether soluble extractive 
value with reference to the air dried drug was calculated.  
 Non volatile ether soluble extractive=  Weight of the dried extract X  100 
       Weight of the sample taken 
 
Determination of volatile ether soluble extractive 
                     2gm of powdered sample was accurately weighed and extracted with anhydrous 
diethyl ether in a continuous extractive apparatus for 20hours. The ether solution was 
transferred to tarred porcelain dish and evaporated spontaneously, dried over phosphorous 
pent oxide for 18hours and the total ether extract was weighed. The extract was heated 
gradually and dried at 105°C to constant weight. The loss in weight represents the volatile 
portion of the extract. 
 Volatile ether soluble extractive=  Weight of the dried extract X  100 
      Weight of the sample taken 
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DETERMINATION OF MOISTURE CONTENT: 
Loss on drying 
                   10 g of the sample substances (without preliminary drying) was taken in a tarred 
evaporating dish.  Use of high speed mill in preparing the samples are avoided. The sample 
in the tarred evaporating dish were placed in the drying chamber (105°C) for 5 hours and 
weigh. Drying and weighing is continued every one hour interval until the difference 
between the two successive weight is not more than 0.25 percent. Constant weight is reached 
when the two consecutive weighing after drying for 30 minutes and cooling for 30 minutes 
in a desiccators, show not more than 0.001 g difference. Percentage moisture content is 
compared with respect to the air dried sample. 
 % Moisture content =  Final weight of the sample X  100 
     Initial weight of the sample 
 
 
PHYTOCHEMICALSTUDIES 
 
The Phytochemical investigation of a plant involves authentication and 
extraction of plant material; qualitative and quantitative evaluations; separation and 
isolation of the constituents of interest; characterisation of the isolated compound. 
Parallel to this may be the assessment of pharmacological activity. 
 
PREPARATION OF EXTRACT 
47 
Extraction is the preliminary step involved in the phytochemical studies. 
Ethanol proves to the universal solvent. As the present study utilizes a combination of 
herbs, ethanol was opted for the extraction of the active constituents from the 
individual plants separately. The method of extraction is HOT 
PERCOLATIONMETHOD. 
HOT PERCOLATION METHOD 
About 200g of coarsely powdered parts of the plant was extracted with  
Ethanol at 60-70°C.  Extract of individual plants were concentrated using rotary 
vacuum evaporator. The percentage yield, colour  and consistency of all the extracts 
were noted and were taken up for further detailed phytochemical and pharmacological 
screening. 
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PRELIMINARY PHYTOCHEMICAL SCREENING 48 
Qualitative analysis for various phytoconstituents in the dried powder and 
extracts of the plant parts of Boerhavia diffusa, Eclipta prostrata, Moringa oleifera, 
Murraya koenigii, Phyllanthus embelica, Tinospora cordifolia  was carried out using 
different reagents as mentioned below. 
DETECTION OF ALKALOIDS 
Dragendroff’s Test 
The powder/extract was dissolved in 5ml of distilled water, to this 5ml of 2M 
Hcl was added. Then 1ml of Dragendroff’s reagent was added and examined for an 
immediate formation of an orange red precipitate. 
Mayer’s Test 
The powder/extract was mixed with little amount of dilute Hcl and Mayer’s 
reagent and examined for the formation of white precipitate. 
Wagner’s Test 
The powder/extract was mixed with Wagner’s reagent and examined for the 
formation of reddish brown precipitate. 
 
DETECTION OF GLYCOSIDES 
Bontrager’s Test 
The powdered plant material/extract was boiled with 1ml of sulphuric acid in a 
test tube for few minutes. The solution was filtered while hot, cooled and shaken with 
equal volume of chloroform. The lower layer of the solvent was separated and shaken 
with half of its volume of dilute Ammonia. Formation of a rose pink to red colour in 
the ammoniacal layer indicates the presence of glycosides. 
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Modified Bontrager’s Test 
The test material was boiled with 2ml of the dilute sulphuric acid. This was 
treated with 2ml of 5% freshly prepared aqueous ferric chloride solution for 5 min and 
shaken with equal volume of chloroform .the lower layer of solvent was separated and 
shaken with half of its volume of dilute ammonia. Formation of a rose pink to red 
colour in the ammoniacal layer indicates the presence of glycosides. 
 
Legal’s Test 
The test material when treated with sodium nitroprusside in pyridine and 
methanolic alkali. Formation of a pink to blood red colour indicates the presence of 
cardiac glycosides. 
DETECTION OF STEROIDS 
Liebermann-Buchards Test 
The powdered drug/extract was treated with few drops of acetic anhydride, 
boiled and cooled. Concentrated sulphuric acid was added from the sides of the test 
tube. If a brown ring is formed at the junction of two layers and upper layer turns 
green, it shows presence of steroids. 
 
Shinoda Test 
To the solution of extract few piece of magnesium turnings and drops of 
concentrated Hcl were added. If a pink crimson red or occasionally green to blue 
colour appears after few minutes, this indicates the presence of flavonoids. 
Alkaline reagent Test 
To the test solution, few drops of sodium hydroxide solution were added. If 
there is a formation of intense yellow colour which turns to colourless on addition of 
few drops of dilute acid, this indicates presence of flavonoids. 
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DETECTION OF CARBOHYDRATES 
Molisch’s Test 
To the test solution, few drops of alcoholic alpha-napthol and few drops of 
concentrated Sulphuric acid were added through the sides of the test tube. Appearance 
of purple to violet colour ring at the junction indicates the presence of carbohydrates. 
 
Fehling’s Test 
The test solution was mixed with Fehling’s I and II, heated and examined for 
the presence of red colouration for the presence of sugar. 
 
DETECTION OF PHENOL 
Ferric chloride Test 
A small quantity of powdered drug/ extract was dissolved in 2ml distilled 
water and a few drops of 10% aqueous ferric chloride solution was added and 
observed for appearance of blue or  greencolour. 
DETECTION OF PROTIENS 
Biuret Test 
The sample was treated with 5-8 drops of 1% w/w copper sulphate solution 
and 1ml of 5% sodium hydroxide. If a violet colour is formed it indicates the presence 
ofproteins. 
 
DETECTION OF TANNINS 
Lead acetate Test 
The test solution was mixed with basic lead acetate solution and examined for 
formation of white precipitate. 
Ferric chloride Test 
A few drops of 5% aqueous ferric chloride solution was added to 2 ml of 
aqueous extract of the drug and examined for the presence of bluish black colour. 
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DETECTION OF SAPONINS 
A drop of sodium bicarbonate solution was added to the sample and the 
mixture was shaken vigorously and left for 3minutes. Development of any honey 
comb like froth was examined. 
 
DETECTION OF GUMS AND MUCILAGE 
A small quantity of powdered drug/extract was dissolved in 5 to 10 ml  of 
acetic anhydride by means of heat, cooled and 0.05ml of concentrated Sulphuric acid 
was added. Formation of bright purplish red colour indicates the presence of gums  
andmucilage. 
 
DETECTION OF FIXED OILS AND FATS 
A small quantity of extract was pressed between two filter papers. An oily 
stain on filter paper indicates the presence of fixed oils andfats. 
 
 FLUORESCENCE ANALYSIS 
48,49 
  
Fluorescence analysis was carried out in day light and in UV light. The powdered plant 
material of  Boerhavia diffusa, Eclipta prostrata, Moringa oleifera, Murraya koenigii, 
Phyllanthus embelica, Tinospora cordifolia  and their extracts was treated with various 
reagents and solvents to identify the presence of chromophores. The fluorescence was 
observed in day light and in short and long UV light 254nm and 365nm respectively. 
 
 CHROMATOGRAPHIC ANALYSIS 49,50 
THIN LAYER CHROMATOGRAPHY 
Principle 
It consists of a thin layer of adsorbent coated on a chromatographic plate, the 
mobile phase (developing solvent) flows against gravitational force by means of 
capillary action. The separation is mainly on the differential migration that occurs 
when the solvent flows along the thin layer of stationary phase. The principle  
involved thin layer chromatography isadsorption. 
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TLC PLATE PREPARATION 
The plates were prepared using Stahl TLC spreader. 40gm of silica gel G was 
mixed with 85ml of water to prepare homogenous suspension and poured into the 
spreader. 0.25mm thickness of plates was prepared, air dried until the transparency of 
the layer disappeared and the plates were then dried at 110°C for 30 minutes and kept 
in desiccators. 
 
Mobile phase 
Single or mixture of solvent was selected based on the phytoconstituents 
present in the extracts. Factors such as nature of the components, stationary phase, 
mobile phase, polarity influence the rate of separation of constituents. From various 
trials, best solvent was selected which showed good separation with maximum  
number ofcomponents. 
 
HPTLC FINGERPRINT PROFILE
50 
HPTLC is one of the advanced and versatile chromatographic technique which 
helps in the identification of compound and thereby authentication of purity of herbal 
drugs. It is very quick process. In addition to qualitative detection, HPTLC also 
provides semi-quantitative information on major active constituents of a drug thus 
enabling an assessment of drug quality. 
 
HPTLC serves as a convenient tool for finding the distribution pattern of the 
phytoconstituents which is unique to each plant. The finger print obtained is suitable 
for monitoring the identity and purity of drugs and for detecting adulteration and 
substitution. HPTLC technique is helpful in order to check the identity, purity and 
standardize the quantity of active principles present in the herbal extracts. 
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INSTRUMENT CONDITIONS 
SampleUsed : Combined ethanolic extracts of all six plants. 
Instrument : CAMAG  HPTLC 
HPTLCApplicator : CAMAG Linomat  5 
SAMPLE APPLICATION 
Spray gas                        : Inert gas 
Sample Solvent type      : Methanol 
Dosage speed                  : 150 nl/s 
Pre Dosage Volume      : 0.2 μl 
SEQUENCE 
Syringe size :100 μl 
        No of tracks                : 3 
STATIONARY PHASE 
 
Material : HPTLC Aluminium Sheets Silica Gel 60F 254 
 Manufacturer : E.MERCK KGaA 
MOBILEPHASE 
Solvent : TOLUENE:ETHYL 
ACETATE:METHANOL[2:2:1] 
Solvent Front Position: 70.0mm 
Volume : 10.0ml 
Drying device : Oven 
Temperature : 60°C 
Time  :5 minutes. 
SCANNER : CAMAG TLC Scanner 
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Wavelength    :366 
Lamp     :D2 & W 
Measurement Type   :Remission 
Measurement Mode   :Absorption 
Optical filter    :Second order 
Detector mode  : Automatic 
PM high voltage   :354 V 
 
 
Chromatographic conditions 
The estimation has been done using the following chromatographic conditions. 
Chromatography was performed on a 10*10cm pre-activated aluminium coated silica gel-
Merk 60  F254 plate. Samples were applied to the plate as 6mm wide band with an automatic 
TLC applicator Linomat V with inert gas  flow CAMAG Switzerland 8mm from the bottom. 
  
 QUANTITATIVEANALYSIS 
 
ESTIMATION OF FLAVONOIDS
51 
The total flavonoid content is usually determined spectrophotometrically using Ultra-violet 
spectroscopy.
 
Preparation of Standard Stock solution 
Accurately weighed 25 mg ofQuercetin standard transferred to 100 ml of volumetric flask 
and dissolved with dimethyl sulfoxide(DMSO). The serial dilution (20mcg,40mcg, 
60mcg,80 mcg ,100 mcg) were made with dimethyl sulfoxide. 
 
Preparation Of Test Solution 
The leaf extract was weighed accurately equal to the weight of Standard Quercetin and 
transferred to 100 ml volumetric flask and the extract dissolved with dimethyl sulfoxide 
(DMSO). The serial dilution (20mcg, 40mcg, 60mcg,80 mcg ,100 mcg) were made with 
dimethyl sulfoxide. 
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PROCEDURE 
From the prepared solution of standard and test solutions 2ml was withdrawn from each 
concentration to the test tube and added equal volume of 2% Aluminium Chloride solution to 
every single concentration. Incubate the solution about 10 minute at ambient temperature. 
After 10 minute, measure the absorbance spectrophotometrically at 435 nm with the standard 
and test sample solutions. 
 
ESTIMATION OF PHENOLIC CONSTITUENTS
51 -53 
  Total phenolic content of the extracts were determined using Folin –Ciocalteu’s assay. 
0.5ml extract solutions were mixed with 2.5ml of 10 fold diluted Folin Ciocalteu’s reagent 
and 2.5ml of 7.5% sodium carbonate. After incubation at 40°c for 30 minutes, the 
absorbance of the reaction mixtures was measured at 765nm in a spectrophotometer. Three 
replicates were made for each test sample. Gallic acid was used as a standard and total 
phenolic content of the extract was expressed in mg of Gallic acid equivalents (mg GAE/g 
extract) 
ESTIMATION OF IRON
55 
Method:Flame Absorption 
 WaveLength(nm):248.30 
INSTRUMENT PARAMETERS  
Slit(nm):0.2  
High Voltage(V):275.70 
Lamp Current(mA):3.00  
Types of Flame:Air-C2H2  
Fuel Gas Flow Rate(L/min):1.50 
Fuel Gas Pressure(MPa):0.10  
Combustion-Supporting Gas:Air 
Combustion-Supporting Gas Flow Rate(L/min):5.00 
Combustion-Supporting Gas Pressure(MPa):0.20 
Burner Height(mm):8.0  
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Preparation of Iron standard stock solution: 
About 100 mg of iron powder was accurately weighed and transferred to 
a1000ml volumetric flask. It is dissolved in 25 ml of 6N hydrochloric acid and diluted 
with water to make up the volume. 
 
Preparation of Standard solution: 
2.0ml of Iron standard stock solution was transferred to separate 100ml 
volumetric flask. Contents of each flask was diluted with water and made up to 
volume and mixed to obtain solutions having known concentrations of about 2.0mg of 
iron per ml. 
 
 
Preparation of sample: 
 
1 gram of sample was transferred to a crucible and kept inside a  muffle furnace 
maintained at about 550° for 6 to 12 hours and cooled. About 60ml of hydrochloric 
acid was added and boiled gently on a hot plate or steam bath for 30 minute 
intermittently rinsing the inner surface of the crucible with 6N hydrochloric acid. It 
was cooled, the contents of the crucible was quantitatively transferred to a 100ml 
volumetric flask. The crucible was rinsed with small portions of 6 N hydrochloric acid 
and the rinings were added to the flask. Diluted with water to volume, mixed and 
filtered, discarded the first 5 ml of the filtrate. This solution was diluted  
quantitatively  and  stepwise  if  necessary,  with  0.125N  hydrochloric   acid. 
Procedure: 
The absorbance of the Standard preparations and the assay preparation was 
determined at the iron emission line at 248.3nm with an atomic absorption 
spectrophotometer (Spectrophotometry and Light-Scattering á 851ñ) equipped with an 
iron hollow-cathode lamp and an air-acetylene flame, using 0.125 N hydrochloric acid 
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as the blank. 
 
A graph was plotted using absorbance of standard Vs concentration. From this 
the concentration of the sample was determined. 
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QUANTITATIVE ESTIMATION OF HEAVYMETALS
56
 
Instrumentation parameters: 
The quantitative analysis of heavy metals was done by the inductive coupled 
plasma-optical emission spectroscopy method. 
 
Instrument model: 
PE optima 5300 DV ICP-OES; optical system Dual view-axial or radial. 
 
Detector system: 
Charge coupled detector, (UV-visible detector which is maintaining at -40°C) to 
detect the intensity of the emission line. 
 
Light source: 
The Torch is positioned horizontally in the sample compartment along the central 
axis of the spectrometer optics. Changing from axial to radial viewing is a simple software 
command and is accomplished by computer control of a mirror located in the optical path. 
The torch assembly of this system comprises of two concentric quartz tubes. 
 
Standard alumina injector: 2.0mm inner diameter 
 
Spray chamber: Scott type 
 
Nebulizer: cross flow gem type 
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Preparation of sample by acid digestion method: 
50mg of the powder was treated with a mixture of sulphuric acid:water in the ratio 
of 4:1 in a kjeldahl flask and heated continuously till the solution was colourless. The 
sample mixture was then transferred in a 25ml volumetric flask and made upto the volume 
with distilled water. Blank solution was prepared as above without  sample. 
 
The standard of Arsenic, Lead, Mercury and Cadmium were prepared as per the 
protocol and the calibration curve was developed for each of them. 
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 PHARMACOLOGICALSTUDIES 
 
EVALUATION OF ANTI-ANAEMIC ACTIVITY 
Experimental animals 
Healthy wistar albino rats of either sex weighing 150-220g were procured from 
Animal Experimental Laboratory, Madras Medical College, Chennai-03. The study was 
approved by the Institutional Animal Ethical Committee of Madras medical College 
Chennai. Which is certified by the committee for the purpose of control and supervision of 
experiments of animals, India (CPCSEA).The Approval number:IAEC/MMC/O5/2016  
Dated: 21.11.2016 
 
The animals were kept individually in a clean and dry metallic cages and 
maintained in a well-ventilated animal house at a room temperature of 22±2° and for 12 
hours light and 12 hours dark cycle. The animals were fed with standard pellet diet and 
water ad libitum. 
 
Acute toxicity studies
57, 58, 59,60,61,62,63
 
The acute toxicity studies have already been done as per OECD guide lines 
423 for the individual plants. They  are  safe upto 2000-4000mg/kg. Since the present study 
deals with combined formulation,  acute toxicity studies for the combined extracts were 
done . 
 
Anti-anaemic activity 
Vit.B12 syrup as standard and phenyl hydrazine to induce anaemia, all the 
chemicals used in the study were of analytical grade. 
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Phenyl hydrazine induced anaemic model 
64
 
This is one of the methods used in evaluating anti-anaemic activity. Anaemia was 
induced in adult wistar albino rats of either sex by oral administration of phenyl hydrazine 
10mg/kg for eight days. The rats with haemoglobin concentration lower than the normal 
(13g/dl) were recruited for the study. 
 
Procedure 
The recruited animals were divided into 5 groups each containing 6 rats; they are 
treated with phenylhydrazine to induce anaemia from 1 to 8 days, except   positive 
group. The standard group receives vit.B12 as standard, group IV and V animals are treated 
with 200mg/kg and 400mg/kg of polyherbal extractfrom 9
th 
day to 60
th 
day respectively. 
Blood is collected on initial day after induction  of anaemia and 60
th 
day after completion of 
treatment. Haematological measurements are made using suitable chemical, electrical and 
microscopical methods. Anti-anaemic activity of the polyherbal extract was calculated by 
statisticalmethods. 
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Table 7.1  :  EXPERIMENTAL DESIGN 
 
 
 
 
 
 
 
 
 
 
 
 
S.No 
 Group  No.of 
animals 
Name of the 
group 
Treatment 
1 I 6 Positive control Receives vehicle for 60 days 
2 II 6 Negative control 
Treatment with PHZ 10mg/kg from day 1 
to day 8 orally 
 
3 
 
III 
 
6 
 
Standard 
Treatment with vit. B12 from 9
th 
day to 60
th 
day orally 
 
4 
 
IV 
 
6 
 
Test dose 1 
Treatment with test dose 1(  200mg/kg) 
from 9
th 
- 60
th 
day 
Orally 
 
5 
 
V 
 
6 
 
Test dose 2 
Treatment with test dose 2 ( 400mg/kg) 
from 9
th _
 60
th 
day 
Orally 
Total  
   30 animals  
Duration of the study is 60 days 
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Evaluation of Anti-anaemic activity-Haematological parameters 
65
 
The complete blood count (CBC) was measured before the induction of anaemia, 
after the induction of anaemia and after drug treatment using Sysmex Automated 
haematology Analyser. The white blood cells, red blood cells, mean corpuscular volume, 
mean corpuscular haemoglobin, mean corpuscular haemoglobin concentration are 
counted using the direct current detection method with coincidence correction and flow 
cytometer. The haematocrit was done directly based on the red cell count and volume 
detection of each individual RBC. Haemoglobin analysis was conducted using Non- 
cyanidemethod. 
Statistical analysis 
The data was subjected to analysis of variance (ANOVA). P values < 0.05 was 
considered significant. 
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FORMULATION OF CAPSULES 
 
Prior to  formulation  process the ethanolic extracts were subjected to freeze drying process .The 
extracts were dried for a period of time  according to their rate of drying . The lyophiliser was 
made utilized in the Pharmaceutics Laboratory, of our college. 
 
 
The dried extracts were weighed accurately to 2 gram individually. The weights of the chosen 6 
plants extracts get summed up to 12gram of the extracts. Magnesium carbonate and Calcium 
Carbonate each 4.8 gram were weighed and mixed with the extracts. They act as adsorbents. 
They were mixed by Trituration method. After trituration, the mixed powder blend was passed 
through sieve no.26. The fine powder so obtained was subjected to preformulation studies.  
   
PREFORMULATION STUDIES
66 
 
Prior to formulation, it is essential that fundamental physical and chemical properties of the drug 
molecule and other derived properties of the drug powder are determined. This information 
decides many of the subsequent events and approaches in formulation development. This first 
learning is known as Preformulation. It aims to optimize the process of turning a drug into a drug 
product. During preformulation the physiochemical properties of the drug candidate are 
determined. 
 
 
 
DETERMINATION OF THE GRANULES PARAMETERS 
 BULK DENSITY 
 TAPPED DENSITY 
 COMPRESSIBILITY INDEX 
 HAUSNER’S RATIO 
 ANGLE OF REPOSE 
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BULK DENSITY 
The bulk density of a powder is dependent on particle packing and changes as the powder 
consolidates. A consolidated  powder is likely to have a greater arch strength than a less 
consolidated one and may therefore be more resistant to powder flow. 
 
PROCEDURE 
Weighed amount of the powder (m i.e mass of the powder) is transferred to a measuring 
cyclinder and  its volume V is measured. From the values, the bulk density of the powder is 
calculated using the following formula: 
   
BULK DENSITY=   MASS OF POWDER (m) 
               BULK VOLUME (V) 
 
 
FIGURE 7.1, 7.2:MEASUREMENT OF TAPPED DENSITY AND ANGLE OF REPOSE. 
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TAPPED DENSITY 
Weighed amount of the powder (m i.e mass of the powder) is transferred to a measuring cylinder 
and  its volume V is measured. The cyclinder is tapped mechanically. The volume of 200 
tappings is noted. This is called the tapped volume. 
 
  TAPPED DENSITY= MASS OF POWDER (m) 
                TAPPED VOLUME(Vf) 
 
 
COMPRESSIBILITY INDEX 
It is an indirect method to determine the flow of  powders. As it was developed by a scientist 
called Carr, henced named after the Carr’s index. It is defined as the direct measure of the 
potential powder or arch or bridge strength and stability. It is calculated by the equation 
  % COMPRESSIBILITY = TAPPED DENSITY – BULK DENSITY    x100 
          TAPPED DENSITY  
 
 
 
HAUSNER’S RATIO 
Hausner  found that the ratio (Vo/Vf) was related quantitatively to  interparticulate friction.  
   
                   HAUSNER’S RATIO = TAPPED DENSITY   x 100 
                               BULK DENSITY    
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ANGLE OF REPOSE 
 As there is a relationship between interparticulate cohesion and Angle of Repose, it proves to be 
a quantifying method of powder flow. There are many different methods of determining it .They 
are as Fixed height cone, Fixed base cone , Titlting table, Rotating Cyclinder. In my present 
study I performed the Fixed height Cone method. Angle of repose was calculated from the 
formula: 
  ANGLE OF REPOSE= Tan 
-1
(h/r) 
   h=height of the pile 
   r=radius of the circle 
 
 
 
 
 
 
Table 7.2: General flow characterstics 
FLOW PROPERTY ANGLE OF 
REPOSE 
CARR’S INDEX HAUSNER’S 
RATIO 
Excellent 25-30 <10 1.00-1.11 
Good 31-35 11-15 1.12-1,18 
Fair 36-40 16-20 1.19-1.25 
Passable 41-45 21-25 1,26-1.34 
Poor 46-55 26-31 1.35-1.45 
Very poor 56-65 32-37 1.46-1.59 
Very very poor >66 >38 >1.60 
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FORMULATION OF CAPSULES
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TABLE7.3:LIST OF MATERIALS USED IN THE FORMULATION 
S.NO INGREDIENT USE 
1. Boerhavvia diffusa Active ingredient  
2. Eclipta prostrate Active ingredient 
3. Moringa oleifera Active ingredient 
4. Murraya koenigii Active ingredient 
5. Phyllanthus embelica Active ingredient 
6. Tinospora cordifolia Active ingredient 
7. Magnesium oxide Adsorbent 
8. Calcium Carbonate Adsorbent 
9. Lactose Diluents  
10. Magnesium stearate Lubricant  
11. Sodium Starch Glycolate Disintergrant  
 
SELECTION OF CAPSULE SIZE
73 
The volume of material to be filled into the capsule should be determined. Generally, capsules of 
sizes “0” to “4” were readily available in the market and the relationship between the capsule 
size and related body volume to be known at the development stage. For pharmaceutical 
products it is unusual to use a size larger than “0” because of the difficulties in the swallowing 
larger size capsules, what size capsules, whilst size “5” is rarely used due to the difficulties in the 
automatic filling process. Capsule of size “0” were selected to fill the polyherbal formulation. 
 
FILLING OF CAPSULES 
The dried powder extracts, along with the adsorbent were taken. Lactose, 1.2 gram, was added as 
diluents. Magnesium stearate , 1gram was weighed and included as the lubricant. Sodium starch 
glycolate , weighed accurately to 1 gram was added as it aids the disintergration process.  
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Figure 7.2: POLYHERBAL HAEMATINIC CAPSULES 
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EVALUATION OF FINISHED PRODUCT
75
 
 
The developed polyherbal were evaluated for its Description, uniformity of weight, 
disintergration time, moisture content, pH. Determination of uniformity of weight, 
disintergration time, moisture content was performed as per Indian Pharmacopoeial procedures. 
 
DESCRIPTION 
The general appearance of capsule , its visual identity and overall elegance is essential for 
consumer acceptance. The colour, shape, odour, surface texture, and legibility of any identifying 
marking are all noted for the capsules prepared. 
 
AVERAGE WEIGHT AND UNIFORMITY OF WEIGHT 
20 individual capsule were selected at random and this content was weighed and their average 
weight was calculated. Not more than two of the individual weights deviate from the average 
weight by more than the percentage shown in the table and none deviate more than twice that 
percentage. 
Table 7.4:Specification of Average and Uniformity of weight 
S.No DOSAGE FORM      AVERAGE WEIGHT      % DEVIATION 
1.  Capsules <300mg 
>300mg 
           10% 
 
          7.5% 
 
DISINTERGRATION TIME 
This test is done to measure the time taken by the drug to disintergrate in the body. This is done 
to determine whether the capsule disintergrates within the prescribed time when placed in a 
liquid medium under the prescribed experimental conditions. Each capsule was added to each of 
the six tubes of the basket and a disc was added to each of the tube. The tubes were dipped 
in0.1N Hydrochloric acid maintained at 37°C. 
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pH 
The pH value of a solution was determined potentiometrically by means of a digital pH meter. 
The pH meter was caliberated using buffers of 4, 9 and 7 pH. 1g of capsule content,was taken 
and dissolved in 100ml demineralized water. The electrodes were immersed in the solution and 
the pH is measured.       
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
RESULTS AND DISCUSSION 
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8. RESULTS AND DISCUSSION 
 
8.1. PHYSIO-CHEMICAL CONSTANTS 
 
The various ash values for the powders used in the formulation are tabulated in table  
 
 
  Table 8.1: ASH VALUES OF THE POWDERS 
S.No NAME OF 
THE PLANT 
TOTAL 
ASH(%W/W) 
WATER 
SOLUBLE 
ASH 
(%W/W) 
ACID 
INSOLUBLE 
ASH (%W/W) 
SULPHATED 
ASH (%W/W) 
1 Boerhavia 
diffusa 
 4.54±0.34 1.23±0.67 0.91±0.31 4.07±0.13 
2 Eclipta 
prostrata 
2.68± 0.47 0.97±0.11 0.76±0.13 2.12±0.17 
3 Moringa 
oloeifera 
2.56±0.17 0.65± 0.16 0.81±0.16 2.37±0.11 
4 Murraya 
koenigii 
3.12±0.35 0.69±0.14 0.97±0.12 3.04±0.14 
5 Phyllanthus 
embelica 
3.36 ±0.12 0.77±0.05 0.82±0.17 3.29±0.23 
6 Tinospora 
sinensis 
4.78± 0.76 0.63±0.14 0.75±0.09 4.01±0.15 
 
The extractive values of the powders were found to be as tabulated in table  . 
   
Table 8.2: EXTRACTIVE VALUES OF THE POWDERS 
S.No NAME OF 
THE PLANT 
Water 
soluble 
extractive 
 
Alcohol 
soluble 
extractive 
 
Ether soluble 
extractive 
 
Non volatile 
Ether soluble 
extractive 
 
1 Boerhavia 
diffusa 
17.56±1.12 20.12±0.13  3.56±0.67 
 
2.12±0.12 
 
2 Eclipta 
prostrata 
13.43±0.78 24.67±0.34 4.70±1.56 2.09±0.56 
3 Moringa 
oloeifera 
18.67±0.95 21.31±0.45 3.23±1.27 2.78±0.43 
4 Murraya 
koenigii 
10.78±1.56 22.21±0.19 4.51±1.43 2.31±0.13 
5 Phyllanthus 
embelica 
16.37±1.17 25.89±0.24 2.23±1.09 2.09±0.76 
6 Tinospora 
sinensis 
15.95±0.92 20.78±0.52 4.76±1.17 2.13±0.32 
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The results of the loss on drying process are summarized in the table . 
 
Table 8.3:LOSS ON DRYING VALUES OF THE POWDERS 
S.NO NAME OF THE 
PLANT 
LOSS ON DRYING 
1 Boerhavia diffusa 4.38±0.75 
2 Eclipta prostrate 3.12±0.68 
3 Moringa oloeifera 4.23±1.25 
4 Murraya koenigii 3.45±1.12 
5 Phyllanthus 
embelica 
4.34±0.89 
6 Tinospora sinensis 4.45 ±1.09 
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PHYTOCHEMICAL STUDIES 
Preparation of extracts 
The shade dried crude dried drugs of  Boerhavia diffusa, Eclipta prostrata, Moringa oleifera, 
Murraya koenigii, Phyllanthus embelica, Tinospora cordifolia was extracted in soxhlet 
extractor with ethanol . All the extracts were concentrated using rotary vacuum evaporator. 
The percentage yield was calculated for every extract in terms of dried weight of plant 
material. The colour and consistency of the concentrated extracts are given in table no.8.4 
 
  Table 8.4 : Percentage yield of extracts  
 
 
S.NO 
PLANT 
NAME 
METHOD OF 
EXTRACTION 
PHYSICAL 
NATURE 
 
COLOUR 
YIELD 
(%W/W) 
 
1. 
Boerhavia      
diffusa  
 
 
 
 
Continuous Hot 
percolation 
method using 
Soxhlet 
apparatus 
 
 
 
Semisolid 
 
Dark brown 
 
2.16 
 
2. 
Eclipta 
Prostrate 
 
Semisolid 
 
Black  green 
 
3.89 
 
3. 
Moringa  
oleifera 
 
Semisolid 
 
Dark green 
 
5.78 
 
4. 
Murraya 
koenigii 
 
Semisolid 
 
Black green 
 
4.34 
 
5. 
 
Phyllanthus 
embelica 
 
Semisolid 
 
Dark brown 
 
3.12 
 
     6. 
 
Tinospora   
sinensis 
 
Semisolid  
 
Dark brown 
 
2.97 
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QUALITATIVE ANALYSIS 
Qualitative chemical tests 
The coarse powder of the six plants and their ethanolic  extracts were 
subjected to qualitative phytochemical analysis to identify the various 
phytoconstituents present in it, as per the standard procedures. The results are given in 
the table no.8.5 
 
Table 8.5 : Preliminary phytochemical analysis of powder  
 
Chemical 
constituents 
B.diffusa E.prostrata M.oleifera 
 
M.koenigii 
P.embelica 
 
T.sinensis 
Steroids + + + + + + 
Glycosides + _ + + _ _ 
Saponins _ + _ _ + _ 
Flavonoids + + + + + + 
Tannins _ + + _ + _ 
Proteins + _ + + + _ 
Alkaloids + + + + + + 
Carbohydrates + + + + + + 
Terpenoids + + + + + + 
Fats and oils _ + + + + _ 
+ indicates presence , - indicates absence 
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Table 8.6: Preliminary phytochemical analysis of ethanolic extract 
 
Chemical 
constituents 
B.diffusa E.prostrata M.oleifera 
 
M.koenigii 
P.embelica 
 
T.sinensis 
Steroids + + + + + + 
Glycosides + _ + + _ _ 
Saponins _ + _ _ + _ 
Flavonoids + + + + + + 
Tannins _ + + _ + _ 
Proteins + _ + + + _ 
Alkaloids + + + + + + 
Carbohydrates + + + + + + 
Terpenoids + + + + + + 
Fats and oils _ + + + + _ 
+ indicates presence , - indicates absence 
 
Qualitative preliminary phytochemical analysis was performed with different respective 
chemical detecting agent to detect the phytoconstituents and their presence in each extract 
and powder.  
FLUORESCENCE ANALYSIS 
Fluorescence analysis for the extracts and the powdered drugs were carried 
out with various reagents to identify the presence of chromophores. The importance 
of fluorescence analysis is that UV light shows the fluorescent nature of the 
compound whereas fluorescence cannot be observed in day light. Hence it is 
performed according to the standard procedures. The results are shown in Tables 8.7 
to 8.13 
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Table 8.7 : Fluorescence analysis of powder of Boerhavia diffusa 
 
Substance Day light Short UV Long UV 
Powder 
Pale brown 
   Brown Brown 
Powder+ H2O 
Puff brown 
Black Puff brown 
Powder +1N HCl 
Brown 
Black Brown 
Powder +1N HnO3 Brown Black Brown 
Powder + acetic acid Pale yellow Brown Yellow 
Powder +1N NaOH Pale yellow       Brown Yellow 
Powder +alc.NaOH  Dark Yellow      Brown Dark Yellow 
Powder +1N KOH  Dark Yellow      Brown Dark Yellow 
Powder +alc.KOH Yellow    Brown Dark Yellow 
Powder+H2So4 Dark brown    Black Dark brown 
Powder+NH4 Brown     Black Brown 
Powder+I2 Dark brown  Black Dark brown 
Powder+FeCl3 Black Black Black 
Powder+ethanol Pale brown Black Black 
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Table 8.8. Fluorescence analysis of powder Eclipta prostrata 
Substance Day light Short UV Long UV 
Powder 
Green 
Black greenish brown 
Powder+ H2O 
Green 
Black greenish brown 
Powder +1N HCl 
Dark Green 
Black Orange green 
Powder +1N HnO3 Dark Green Black Orange 
Powder + acetic acid Pale Green Dark green Greenish yellow 
Powder +1N NaOH   Pale Green Black Pale green 
Powder +alc.NaOH Pale Green Black Pale green 
Powder +1N KOH Pale Green Black Pale green 
Powder +alc.KOH Pale Green Black Pale green 
Powder+H2So4 Black Black Black 
Powder+NH4 Dark Green Black Green 
Powder+I2 Reddish Brown Black Brown 
Powder+FeCl3 Dark Green Black Brown 
Powder+ethanol Pale Green Black Greenish brown 
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 Table 8.9: Fluorescence analysis of powder of  Moringa oleifera 
 
Substance Day light Short UV Long UV 
Powder 
Green 
Black greenish brown 
Powder+ H2O 
Green 
Black greenish brown 
Powder +1N HCl 
Dark Green 
Black Orange green 
Powder +1N HnO3 Dark Green Black Orange 
Powder + acetic acid Pale Green Dark green Greenish yellow 
Powder +1N NaOH   Pale Green Black Pale green 
Powder +alc.NaOH Pale Green Black Pale green 
Powder +1N KOH Pale Green Black Pale green 
Powder +alc.KOH Pale Green Black Pale green 
Powder+H2So4 Black Black Black 
Powder+NH4 Dark Green Black Green 
Powder+I2 Reddish Brown Black Brown 
Powder+FeCl3 Dark Green Black Brown 
Powder+ethanol Pale Green Black Greenish brown 
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Table8.9 :Fluorescence analysis of powder Murraya koenigii 
 
Substance Day light Short UV Long UV 
Powder 
Green 
Black greenish brown 
Powder+ H2O 
Green 
Black greenish brown 
Powder +1N HCl 
Dark Green 
Black Orange green 
Powder +1N HnO3 Dark Green Black Orange 
Powder + acetic acid Pale Green Dark green Greenish yellow 
Powder +1N NaOH   Pale Green Black Pale green 
Powder +alc.NaOH Pale Green Black Pale green 
Powder +1N KOH Pale Green Black Pale green 
Powder +alc.KOH Pale Green Black Pale green 
Powder+H2So4 Black Black Black 
Powder+NH4 Dark Green Black Green 
Powder+I2 Reddish Brown Black Brown 
Powder+FeCl3 Dark Green Black Brown 
Powder+ethanol Pale Green Black Greenish brown 
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Table 8.10 : Fluorescene analysis of powder of  Phyllanthus embelica 
Substance Day light Short UV Long UV 
Powder 
Brown 
  Black Brown 
Powder+ H2O 
Pale brown 
  Black Puff brown 
Powder +1N HCl 
Brown 
  Black Brown 
Powder +1N HnO3 Pale brown   Brown Brown 
Powder + acetic acid   Yellowish brown   Black Yellow 
Powder +1N NaOH  Yellowish brown   Black Yellow 
Powder +alc.NaOH Pale brown   Black  Dark Yellow 
Powder +1N KOH Pale brown   Black Dark Yellow 
Powder +alc.KOH Pale brown    Black Dark Yellow 
Powder+H2So4 Black    Black Dark brown 
Powder+NH4 Brown    Black Brown 
Powder+I2 Reddish brown     Black Dark brown 
Powder+FeCl3 Blackish green     Black Black 
Powder+ethanol Pale brown     Brown  Black 
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Table8.11 : Fluoresence analysis of  Tinospora sinensis 
 
Substance Day light Short UV Long UV 
Powder 
Pale brown 
  Black Brown 
Powder+ H2O 
Puff brown 
  Black Puff brown 
Powder +1N HCl 
Brown 
  Black Brown 
Powder +1N HnO3 Brown   Brown Brown 
Powder + acetic acid 
Pale brown 
  Black Yellow 
Powder +1N NaOH 
Pale brown 
  Black Yellow 
Powder +alc.NaOH Brown   Black  Dark Yellow 
Powder +1N KOH 
Pale brown 
  Black Dark Yellow 
Powder +alc.KOH 
Pale brown 
   Black Dark Yellow 
Powder+H2So4 Black    Black Dark brown 
Powder+NH4 Brown    Black Brown 
Powder+I2 Reddish brown     Black Dark brown 
Powder+FeCl3 Black     Black Black 
Powder+ethanol Pale brown     Brown  Black 
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Table no. 8.12:  Fluorescence analysis of extracts 
 
        Plants Day light    Short UV Long UV 
 Boerhavia diffusa Brown Black Brown 
 Eclipta prostrata Dark Green Black Dark Green 
 Moringa oleifera  Dark Green Black Dark Green 
 Murraya koenigii Dark Green Black Dark Green 
 Phyllanthus embelica Brown Black Brown 
 Tinospora sinensis Brown Black Brown 
 
No fluorescence was observed for the powder as well as extracts indicating the 
absence of chromophore in the plant. 
 
 
CHROMATOGRAPHIC ANALYSIS 
Thin layer chromatography: 
The ethanolic extract of all the plants were subjected to thin layer 
chromatographic studies using various solvent systems. Several mobile phases were 
tried for the separation of maximum components by trial and error method. The 
solvent system selected was ethyl acetate: formic acid: acetic acid: water (5:3:1:1), 
ethyl acetate: n- butanol:ethanol:water (4:1:0.1:5) and ethanol: glacial acetic acid: 
formic acid:water(3:0.9:0.9:0.5). Rf values were noted down for each selected 
extracts after elution by using different detecting agents such as Dragendroff’s,  
Ninhydrin, Libberman Burchard, Con.Sulphuric acid & Ferric chloride. 
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            Table 8.13 : Rf values of the extract 
S.No   Name of the plant Rf  value  
1.  Boerhavia diffusa 0.57  
2.  Eclipta prostrate 0.76 
3.  Moringa oleifera  0.34 
4.  Murraya koenigii 0.68 
5  Phyllanthus embelica 0.65 
6  Tinospora sinensis 0.49 
 
 
 
Figure 8.1 : TLC of  Moringa oleifera 
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Figure8.2 : TLC of Tinospora Cordifolia 
 
 
Figure 8.3: TLC of Boerhavia diffusaFigure8.4 : TLC of Eclipta prostrata 
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Figure 8.5TLC of  Phyllanthus embelica 
 
 Figure8.6 : TLC of Murraya koenigii 
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FIG8.7  :HPTLC FINGER PRINTING OF THE POLYHERBAL EXTRACT AT 254nm 
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HPTLC FINGER PRINTING OF THE POLYHERBAL EXTRACT AT 366nm  
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  Figure8.8 : HPTLC finger printing – All Tracks   
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FIG8.9  :FINGER PRINT 1 
 
 
 
Fig 8.10: Finger print 2 
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Table 8.14 : HPTLC DATA 
 
Start Start Max Max Max End End Area 
Peak Rf Height Rf Height % Rf Height Area % Assigned substance 
 
 Start Start       
Peak Rf Start 
Height 
Rf Start 
Height 
% Rf Height Area % Assigned 
Substance 
1   0.05    1.6 -0.02  648.9  25.63 -0.01  221.6    9139.8  10.67 unknown * 
2   0.01  222.7  0.00  235.4   9.30  0.05  154.8    6997.7   8.17 unknown * 
3   0.05  155.2  0.09  219.9   8.68  0.13  171.0    8886.5  10.38 unknown * 
4   0.14  170.7  0.28  312.0  12.32  0.31  178.6   24886.6  29.06 unknown * 
5   0.31  179.4  0.34  211.6   8.36  0.36  207.5    5446.5   6.36 unknown * 
6   0.36  207.6  0.40  336.2  13.28  0.47   71.8   14497.5  16.93 unknown * 
7   0.47   71.8  0.49  121.1   4.78  0.55   32.4    3149.2   3.68 unknown * 
8   0.55   32.4  0.59  144.4   5.70  0.63   18.3    3493.3   4.08 unknown * 
9   0.70   17.2  0.73   38.3   1.51  0.75   31.8    1047.8   1.22 unknown * 
10   0.75   32.1  0.81  193.4   7.64  0.85   60.0    6483.6   7.57 unknown * 
11   0.85   60.7  0.86   70.8   2.80  0.91    1.0    1615.7   1.89 unknown * 
 The HPTLC finger printing of the polyherbal ethanolic extracts showed the  
above tabulated Rf values with corresponding peak area. 
 HPTLC fingerprint is one of the versatile tools for qualitative and 
quantitative analysis of active constituents of multicomponent sample and also a 
diagnostic method to find out the adulterants to check purity. 
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ESTIMATION OF IRON 
 
FIGURE 8.11: IRON ESTIMATION 
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        FIGURE 8.12: IRON ESTIMATION 
 
 
 
 
 
 
 
 
 
 
 
 
                                                                     Results and Discussion 
Department of Pharmacognosy, MMC, Chennai-3 Page 94 
 
  Table8.15: Observation table for Iron estimation  
Name Meas ures ABS Conc(ppm) SD RSD(%) Result* 
(Mg) 
Calibration Blank 1 0.0029     
2 0.0022     
3 0.0022     
 0.0024 -- 0.0004 16.9500  
STD1 1 0.0305     
2 0.0302     
3 0.0304     
 0.0304 0.1000 0.0001 0.4585  
STD2 1 0.0932     
2 0.0929     
3 0.0911     
 0.0924 0.3000 0.0011 1.2428  
STD3 1 0.1488     
2 0.1481     
3 0.1497     
 0.1489 0.5000 0.0008 0.5405  
STD4 1 0.2032     
2 0.2028     
3 0.2021     
 0.2027 0.7000 0.0006 0.2835  
Murraya koexigii 1 0.0168     
2 0.0164     
3 0.0158     
 0.0164 0.0557 0.0005 3.1675 0.0557() 
Moringa oleifera 1 0.0134     
2 0.0135     
3 0.0144     
 0.0138 0.0469 0.0006 4.0801 0.0469() 
Phyllanthus  emblica 1 0.0171     
2 0.0177     
3 0.0177     
 0.0175 0.0595 0.0004 2.0168 0.0595() 
Eclipta prostate 1 0.0183     
2 0.0184     
3 0.0182     
  0.0183 0.0622 0.0001 0.6384 0.0622() 
Tinospora sinensis 1 0.0478     
2 0.0480     
3 0.0485     
 0.0481 0.1634 0.0003 0.7169 0.1634() 
Boerrhavia diffusa 1 0.0266     
2 0.0257     
3 0.0265     
 0.0263 0.0894 0.0005 1.8780 0.0894() 
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T
a
ble 8.16: Results for Iron estimation of ethanolic extracts. 
 
 
  
 
The above table explains clearly that the chosen plants contain Iron in considerable high 
amounts. Thus it throws a light on the fact that, they can be used as the ingredients for the 
poly herbal formulation to treat anemia. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S.No Name of the plants(Ethanolic Extracts) Concentration of Iron 
(ppm) 
1. Murraya koenigii 0.0557 
2. Moringa oleifera 0.0469 
3. Phyllanthus embelica 0.0595 
4. Eclipta prostrata 0.0622 
5. Tinospora sinensis 0.1634 
6. Boerhavia diffusa 0.0894 
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Estimation of heavy metals 
Heavy metals in the sample was digested by wet digestion or dry digestion or 
high pressure microwave digestion and the amount of heavy metals were  determined, 
i.e. arsenic (As), cadmium (Cd), lead (Pb) and mercury (Hg) by using  graphite 
furnace atomic absorption spectrophotometer (GF-AAS) and flow injection analysis 
system-atomic absorption spectrophotometer (FIAS-AAS) and the values were 
compared with the WHOstandards. 
Table No.8 .17:  Estimation of heavy metals 
 
 
Element 
 
    Mercury 
 
 
Arsenic 
 
        Lead 
 
      Cadmium 
 
Boerhavia 
diffusa 
Mercury 
 
Nil 
 
Nil 
 
0.21 
 
Nil 
 
Eclipta 
prostrate 
 
Nil 
 
Nil 
 
0.20 
 
Nil 
 
Moringa 
oleifera 
 
Nil 
 
Nil 
0.22 
 
 
Nil 
 
Murraya 
koenigii 
 
Nil 
 
Nil 
0.21 
 
 
 
 
Nil 
Phyllanthus         
embelica 
 
Nil 
Nil 0.19  
Nil 
Tinospora 
sinensis 
Nil Nil 0.22  
Nil 
Specification 
as per WHO 
Guidelines 
Not more 
than 
0.5ppm 
Not more than 
5.0ppm 
Not more than 
10ppm 
 
Not more than       
0.3ppm 
 
The estimation of heavy metals in the sample revealed heavy metals are within 
the prescribed limits. It is safe and does not cause any harm on consumption
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QUANTITATIVE ESTIMATION  
 
 
Table 8.18: Spectrophotometric absorbance of Standard and Sample 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Standard Calibration Curve for Quercetin 
 
 
 
FIGURE 8.13 : DETERMINATION OF FLAVANOIDS 
y = 0.0028x + 0.0687 
R² = 0.9726 
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Determination of Flavanoids  
Quercetin
Linear (Quercetin)
  S.No Concentration of standard 
solution(µg/ml) 
Absorbance(435nm) 
1. 20 
0.135 
2. 40 
0.175 
3. 60 
0.213 
4. 80 
0.306 
5. 100 
0.347 
6. Boerhavia diffusa 
0.178 
7. Eclipta prostrata 
0.165 
8. Moringa oleifera 
0.159 
9. Murraya koenigii 
0.167 
10. Phyllanthus embelica 
0.198 
11. Tinospora sinensis 
0.156 
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From the replicate absorbance value obtained by the spectrophotometry, the calculation 
of concentration of flavonoid present in 1gm of the extract was calculated by applying the 
dilution factor. The concentration of each extract obtained  
 
TABLE 8.19:PERCENTAGE YIELD OF TOTAL FLAVONOID 
S.NO SAMPLE CONCENTRATION 
OBTAINED 
(mg/gm) 
PERCENTAGE OF 
FLAVONOIDS  PRESENT 
1.  Boerhavia diffusa 43.43 4.3 
2.  Eclipta prostrate 39.85 4 
3.  Moringa oleifera 33.72 3.4 
4.  Murraya koenigii             36.12 3.7 
5.  Phyllanthus embelica 47.67 5.1 
6.  Tinospora sinensis             37.32 3.8 
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TOTAL PHENOLIC CONTENT   
Total phenolic content of the individual extract was determined and compared 
with that of standard.  
TABLE 8.20: Spectrophotometric absorbance of Standard and Sample 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Standard Calibration Curve for Gallic acid 
To determine the accuracy of the phenolic compound by plotted the standard absorbance 
obtained from spectrophotometrically. The calibration curve done by made serial dilution 
(20mcg, 40mcg, 60mcg, 80mcg) of Gallic acid Standard stock solution, the absorbance plotted 
against concentration 
 
 
 
 
 
 
 
  S.No Concentration of standard 
solution(µg/ml) 
Absorbance(435nm) 
1.  
20 
0.156 
2.  
40 
0.194 
3.  
60 
0.304 
4.  
80 
0.390 
5.  
Boerhavia diffusa 
0.266 
6.  
Eclipta prostrata 
0.231 
7.  
Moringa oleifera 
0.216 
8. Murraya koenigii 0.242 
9. Phyllanthus embelica 0.278 
10. Tinospora sinensis 0.215 
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FIGURE 8.14 : STANDARD CALIBRATION CURVE FOR GALLIC ACID 
 
 
 
TABLE 8.21:PERCENTAGE OF PHENOLIC CONTENT PRESENT IN EACH 
EXTRACT 
S.NO Sample Concentration 
Obtained (mg/gm) 
Percentage of phenolic content 
Present(%w/w) 
1.  Boerhavia diffusa 204.33 20.4 
2.  Eclipta prostrata 168.27 16.8 
3.  Moringa oleifera 108.17 10.8 
4. Murraya koenigii 153.34 14.5 
5. Phyllanthus embelica 234.19 22.1 
6. Tinospora sinensis 178.41 17.5 
 
 
y = 0.0041x + 0.058 
R² = 0.9695 
0
0.1
0.2
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0.4
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Determination of total phenolic 
content 
Gallic acid
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PHARMACOLOGICAL ACTIVITY 
 
ACUTE TOXICITY STUDIES 
The polyherbal extract was found safe. No abnormalities were observed in the body weight, 
behavior and blood parameters. No morbidity or mortality was observed. The extracts were 
safe upto to the dose 2000mg/kg.   
EVALUATION OF ANTI-ANAEMIC ACTIVITY 
Effect of the combined ethanolic extracts (200mg/kg and 400mg/kg) on the 
haematological parameters compared with that of the standard in following tables and 
graphs. 
 
   Table 8.22  : Effect of Polyherbal extract on RBC count 
 
 
S. 
NO 
 
PARAMETERS 
 
GROUP 
1 
 
GROUP 
2 
 
GROUP 
3 
 
GROUP 
4 
 
GROUP 
5 
1 INITIAL 
7.3± 
0.45** 
7.09± 
0.65* 
7.29± 
0.57*** 
7.39± 
0.53*** 
7.4± 
0.44*** 
2 INDUCED 
6.37± 
0.43** 
5.69± 
0.69* 
5.47± 
0.47*** 
4.64± 
0.55*** 
4.86± 
0.74*** 
 
3 
 
TREATMENT 
7.37± 
0.27** 
6.75± 
0.59* 
6.91± 
0.58*** 
7.63± 
0.63*** 
7.77± 
0.81*** 
 
*P< 0.005, **p< 0.01, ***p< 0.0001 as compared to positive control and negative control 
.The data was analysed using one way Analysis of Variance (ANOVA) 
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FIGURE 8. 15:Effect of Polyherbal extract on RBC count 
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TABLE 8.23   : Effect of Polyherbal extract on Haemoglobin count 
 
 
S. 
NO 
 
PARAMETERS 
 
GROUP 
1 
 
GROUP 
2 
 
GROUP 
3 
 
GROUP 
4 
 
GROUP 
5 
1 INITIAL 
14.28± 
0.53** 
14.61± 
0.74* 
14.51± 
0.36*** 
14.28± 
0.53*** 
14.45± 
0.75*** 
2 INDUCED 
7.45± 
0.57** 
6.566± 
0.49* 
6.138± 
0.26*** 
5.703± 
0.46*** 
7.618± 
0.55*** 
3 TREATMENT 
   14.81± 
0.61** 
6.58± 
0.36* 
15.79± 
0.60*** 
17.69 ± 
1.50*** 
18.31± 
1.54*** 
 
*P< 0.005, **p< 0.01, ***p< 0.0001 as compared to positive control and negative control  
.The data was analysed using one way Analysis of Variance (ANOVA). 
 
 
 
 
FIGURE 8.16  : Effect of Polyherbal extract on Haemoglobin count 
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Table 8.24 : Effect of Polyherbal extract on Haematocrit 
 
S. 
NO 
 
PARAMETERS 
GROUP 
1 
GROUP 
2 
GROUP 
3 
GROUP 
4 
GROUP 
5 
 
1 
 
INITIAL 
42.85± 
2.15** 
42.86± 
1.75* 
43.266± 
5.40*** 
42.13± 
1.66*** 
42.77± 
4.84*** 
 
2 
 
INDUCED 
41.31± 
4.48** 
30.1± 
1.51* 
35.38± 
3.44*** 
34.97± 
2.86*** 
37.73± 
4.34*** 
 
3 
 
TREATMENT 
42.99± 
4.73** 
29.8± 
1.72* 
44.39± 
4.16*** 
47.031± 
5.48*** 
48.49± 
2.48*** 
 
*P< 0.005, **p< 0.01, ***p< 0.0001 as compared to positive control and negative control 
.The data was analysed using one way Analysis of Variance (ANOVA). 
 
 FIGURE 8.17: Effect of Polyherbal extract on Haematocrit 
 
 
    
42.85 42.86 43.266 42.13 42.77 41.31 
30.1 
35.38 34.97 37.73 
42.99 
29.8 
44.39 47.031 
48.49 
1 2 3 4 5
Effect of Polyherbal Extract on 
Haematocrit 
initial induced treatment
                                                                               Results and Discussion 
 
 
Department of Pharmacognosy, MMC, Chennai-3 Page 105 
  
 
 
 
 
 
 
 
 
 
 
Table 8.25 : Effect of Polyherbal extract on MCV 
 
 
S.NO 
 
PARAMETERS 
 
GROUP 
1 
 
GROUP 
2 
 
GROUP 
3 
 
GROUP 
4 
 
GROUP 
5 
 
1 
 
INITIAL 
61.7± 
1.90** 
60.7± 
1.86* 
62.56± 
1.53*** 
61.63± 
1.97*** 
62.68± 
1.83*** 
 
2 
 
INDUCED 
61.73± 
1.089** 
32.75± 
3.62* 
32.43± 
2.92*** 
32.53± 
2.71*** 
33.08± 
4.03*** 
 
3 
 
TREATMENT 
64.1± 
1.04** 
30.71± 
6.097* 
43.83± 
3.34*** 
56.65± 
4.65*** 
58.33± 
6.45*** 
    
*P< 0.005, **p< 0.01, ***p< 0.0001 as compared to positive control and negative control 
.The data was analysed using one way Analysis of Variance (ANOVA). 
 
 
61.7 60.7 62.56 61.63 62.68 61.73 
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64.1 
30.71 
43.83 
56.65 58.33 
1 2 3 4 5
Effect of Polyherbal Extract on MCV  
initial induced treatment
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Table8.26  : Effect of Polyherbal extract on MCH 
 
 
S.NO 
 
PARAMETERS 
 
GROUP 
1 
 
GROUP 
2 
 
GROUP 
3 
 
GROUP 
4 
 
GROUP 
5 
1 INITIAL 
18.76± 
1.33** 
17.85± 
0.74* 
18.36± 
1.69*** 
17.71± 
1.29*** 
18.45± 
1.33*** 
2 INDUCED 
18.86± 
1.16** 
14.31± 
1.39* 
15.23± 
0.81*** 
13.35± 
0.87*** 
13.75± 
0.85*** 
3 TREATMENT 
18.85± 
1.06** 
13.25± 
1.07* 
16.75± 
0.83*** 
18.66± 
1.675*** 
19.38± 
1.40*** 
 
*P< 0.005, **p< 0.01, ***p< 0.0001 as compared to positive control and negative control  
.The data was analysed using one way Analysis of Variance (ANOVA). 
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FIGURE 8.18:  Effect of Polyherbal extract on MCH 
 
 
 
 
 
 
 
 
 
Table 8.27  : Effect of Polyherbal extract on MCHC 
 
 
S.NO 
 
PARAMETERS 
 
GROUP 
1 
 
GROUP 
2 
 
GROUP 
3 
 
GROUP 
4 
 
GROUP 
5 
1 
 
INITIAL 
29.31± 
1.72** 
28.26± 
1.63* 
29.78± 
1.26*** 
27.96± 
1.56*** 
28.91± 
1.8*** 
2 
 
INDUCED 
29.83± 
1.021** 
24.53± 
1.69* 
24.91± 
2.221*** 
23.95± 
1.35*** 
23.4± 
1.42*** 
3 
 
TREATMENT 
29.95± 
1.005** 
23.96± 
1.42* 
25.56± 
2.26*** 
28.91± 
2.07*** 
29.77± 
4.14*** 
 
18.76 17.85 18.36 17.71 18.45 
18.86 
14.31 15.23 13.35 13.75 
18.85 
13.25 
16.75 
18.66 19.38 
1 2 3 4 5
Effect of Polyherbal Extract on MCH  
Series1 Series2 Series3
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*P< 0.005, **p< 0.01, ***p< 0.0001 as compared to positive control and negative control 
.The data was analysed using one way Analysis of Variance (ANOVA). 
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PREFORMULATION STUDIES 
The preformulation studies revealed that the powder flow determining parameters like bulk 
density, tapped density, Carr’s Index, Angle of Repose, Hausner’s ratio were all within the 
standard flow characterstics. The polyherbal extract powder had good flow peoperty. 
PHARMACEUTICAL EVALUATION OF POLYHERBAL CAPSULES 
The formulated capsules were evaluated for the appearance, uniformity in weight and 
disintegration time. 
Table 8.30 : ORGANOLEPTIC CHARACTERS  
S.NO NAME OF THE 
TEST 
OBSERVATIONS 
1. Description Greenish black powder contained in Blue cap/ transparent 
body “0” size capsule 
2. Colour  Greenish black powder 
3. Odour Characterstic odour 
4. Taste Bitter 
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TABLE 8.31 : PHYSICAL PARAMETERS 
S.NO NAME OF THE TEST OBSERVATIONS 
1. pH(1% Aqueous Solution) 7.33±0.21 
2. Moisture Content 3.2% ± 0.14 
3. Average Weight 253mg ± 5.65 
4. Uniformity of weight RSD : 3.8 
5. Disintegration time 2’32 ± 0.34 
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SUMMARY AND CONCLUSION 
There are several synthetic drugs available and are still on the way being discovered by many 
young research fellows of our kind, but still the affinity for herbal drugs hasn’t reduced. People 
feel secure in using the plant based drugs for their chronic diseases. 
People  still rely on nature which has blessed human kind with abundant medicinal plants for 
prevention and cure of disease. 
 
The prevalence of anaemia is increasing worldwide. Though medicines are available for the 
treatment of anaemia in allopathic system of medicine, its compliance is an issue due to 
sideeffects. 
 
Therefore this study is an attempt to formulate and evaluate the folklore claims of  six 
indigenous herbs viz., Boerhavia diffusa, Eclipta prostrata, Moringa oleifera, Murraya 
koenigii,Phyllanthus embelica, Tinospora sinensis,as capsules for the treatment of anaemia. 
 
The selected plant powders were subjected to preliminary evaluation. The physio-
chemical constants like ash values, extractive values, loss on drying, were performed. The 
results obtained proved the procured raw materials were of good standard. 
Phytochemical analysis was performed for the powder as well as the ethanolic extracts of 
the plants. It showed the presence of major phyto constituents like alkaloids, flavanoids, 
terpenoids, steroids ,carbohydrates, proteins. 
Chromatograhical studies revealed the various Rf  values, which ensures the presence of the 
various phytoconstituents. 
The dried extracts were transformed to powder, and subjected to pre-formulation studies 
and it proved the powder had good flow characterstics. 
Hence it was filled in capsules and evaluated for the parameters like,appearance, 
uniformity in weight, disintergration time. The results were good.     
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The in-vivo Anti-anaemic activity was carried out by phenyl hydrazine induced anaemic 
model using the polyherbal extract. Two doses of the polyherbal extract i.e 200mg/kg and 
400mg/kg orally were used for anti-anaemic evaluation. The studies indicates that polyherbal 
extract at the dose of 400mg/kg has better anti-anaemic activity. The haematological studies 
also showed increase in RBC and haemoglobin content and  the overall improvement in blood 
quality. These changes are markedly good at higher testdose. 
 
Hence, from these studies it is concluded that the formulation proves effective in the 
treatment   of anemia and therefore is haematinic in nature! 
 
 The future studies are recommemded in the stability determination areas for the 
formulated polyherbal capsules. It also includes the clinical trials,to prove the haematinic activity 
of the capsules in human subjects. 
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